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Abstract
Genetic interactions of factors that regulate alternative RNA
splicing in the male germ line of Drosophila

Publication No.________

Shanzhi Wang, M.S.
Supervisory Professor: William Mattox, Ph.D.

Alternative RNA splicing is a critical process that
contributes variety to protein functions, and further controls cell
differentiation and normal development. Although it is known that
most eukaryotic genes produce multiple transcripts in which splice
site selection is regulated, how RNA binding proteins cooperate to
activate and repress specific splice sites is still poorly
understood. In addition how the regulation of alternative splicing
affects germ cell development is also not well known. In this study,
Drosophila Transformer 2 (Tra2) was used as a model to explore both
the mechanism of its repressive function on its own pre-mRNA
splicing, and the effect of the splicing regulation on
spermatogenesis in testis. Half-pint (Hfp), a protein known as
splicing activator, was identified in an S2 cell-based RNAi screen
as a co-repressor that functions in combination with Tra2 in the
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splicing repression of the M1 intron. Its repressive splicing
function is found to be sequence specific and is dependent on both
the weak 3’ splice site and an intronic splicing silencer within
the M1 intron. In addition we found that in vivo, two forms of Hfp
are expressed in a cell type specific manner. These alternative
forms differ at their amino terminus affecting the presence of a
region with four RS dipeptides. Using assays in Drosophila S2 cells,
we determined that the alternative N terminal domain is necessary
in repression. This difference is probably due to differential
localization of the two isoforms in the nucleus and cytoplasm. Our
in vivo studies show that both Hfp and Tra2 are required for normal
spermatogenesis and cooperate in repression of M1 splicing in
spermatocytes. But interestingly, Tra2 and Hfp antagonize each
other’s function in regulating germline specific alternative
splicing of Taf1 (TBP associated factor 1). Genetic and cytological
studies showed that mutants of Hfp and Taf1 both cause similar
defects in meiosis and spermatogenesis. These results suggest Hfp
regulates normal spermatogenesis partially through the regulation
of taf1 splicing. These observations indicate that Hfp regulates
tra2 and taf1 activity and play an important role in germ cell
differentiation of male flies.
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CHAPTER ONE
General Introduction
In the original idea of the central dogma (Crick, 1970; Crick,
1958), RNA was simply thought to be a middle carrier during a flow
that transferred genetic information from DNA to protein. DNA
encodes all the information necessary to make final protein
products, while RNA will be used passively to copy that information
from DNA and direct protein synthesis. Until 1977 (Berget et al.,
1977) when RNA was discovered to be spliced before entering the
cytoplasm to direct protein synthesis, people realized that there
are many regulatory steps at the RNA level during gene expression.

1. pre-mRNA splicing
Eukaryotic genes contain both exons and introns. Exons are the
regions that will be kept in final mRNAs but are split by noncoding introns. To make coding information intact for future
protein synthesis, introns will be cut out and other parts will be
connected together to form complete and useful information. This
process is called pre-mRNA splicing.
Although split genes exist in eukaryotic cells, their
prevalence in the genome is highly diverse across the species. In
budding yeast, less than 5% of genes have introns and undergo RNA
splicing. However this percentage can reach more than 90% in the
human genome (Ares et al., 1999; Neuveglise et al., 2011; Pan et
al., 2008; Shieh et al., 2011; Wang et al., 2008).
To get rid of introns from a linear nucleotide chain, splicing
signals are required to distinguish introns from exons. In general
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splicing signals are the short sequences residing the exon-intron
boundaries and within the introns. The 5’ splice site occurs at a
short conserved consensus sequence with GU as the most 5’ end of
the intron. Near the opposite end of the intron there are two
signals: an AG dinucleotide at the most 3' end that is preceded a
polypyrimidine tract and a loosely conserved branch site sequence
(Figure 1-1). Briefly, intron splicing takes place in two steps.
First, the 2’-hydroxyl of an adenosine nucleotide at the branch
point attacks the phosphate of the guanosine nucleotide at the 5’
splice site. This will release a free 5’ exon and a lariat product
including the rest of the transcript. Second, the free 5’ exon will
use its 3’-hydroxyl to attack the phosphate of 3’ splice site and
ligate with the downstream exon, in the meantime the lariat intron
is released (Figure 1-2).
RNAs have many important functions including catalysis. The
“RNA world” hypothesis (Cech, 2011) suggests that RNA itself has
the potential to function as an enzyme. Actually, the splicing
reactions of some special introns could be catalyzed just by RNA
itself (Bonen and Vogel, 2001; Nielsen and Johansen, 2009). However
in terms of pre-mRNA splicing, proteins and protein-RNA complexes
are required for RNA splicing to be accomplished correctly. These
protein factors will recognize the splice sites, recruit other
factors and form the catalytic complexes by communicating with each
other to finally complete intron splicing (Wahl et al., 2009).
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Figure 1-1. Two steps of catalytic reactions of pre-mRNA splicing
Gray boxes indicate exons and horizontal thin lines indicate
introns. 5’ and 3’ represent 5’ splice site and 3’ splice site
within the intron. GU are two starting nucleotides and AG are the
ending nucleotides of the intron. “A” represents branch point site.
Two catalytic steps are indicated as numbers. Reactions between
residue groups are represented by red arrow lines.
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Figure 1-2. Basic splicing signals for pre-mRNA splicing

Exons are shown as gray boxes and intron is shown as the horizontal
line. Polypyrimidine tract is shown as the dash line. GU/AG
represent the nucleotides in the boundary between the exons and the
intron.

	
  

	
  

4	
  

It is known that the U1 small nuclear RNA particle (U1 snRNP)
recognizes the 5’ splice site, splicing factor 1 (SF1) binds to the
branch point, and U2 snRNP auxiliary factors (U2AFs) recognize the
3’ splice site and the polypyrimidine tract. At this point, the
RNA-protein complex is called E complex. The U2 small nuclear RNA
particle (U2 snRNP) is then recruited by interacting with U2AF,
replacing SF1 and base-pairing with the branch point in an ATPdependent manner to transform the E complex into A complex. Once a
stable spliceosome is formed, tri-snRNPs (U4-U5-U6 snRNPs) will
join in and transform A complex into B complex. After U1 and U4
snRNPs leave and the complex finishes rearrangement, the whole
spliceosome becomes active and performs the catalytic function to
complete splicing in two steps as discussed above (Black,
2003)(Figure 1-3).
With the genome becoming more complex, higher eukaryotes
contain more multi-intron genes (Kim et al., 2008), and RNA
splicing becomes more flexible to have many choices of determining
which exons will be included in the final messenger RNAs. Thus this
process eventually becomes alternative splicing instead of simple
RNA splicing (or constitutive splicing). Alternative splicing
patterns include alternative 5’ splice sites, alternative 3’ splice
sites, exon skipping, the use of mutually exclusive exon and intron
retention (Figure 1-4). Alternative splicing is thus a highly
versatile mechanism for producing different mRNA isoforms from a
single primary transcript.
Alternative RNA splicing is an essential process for human
cells to produce various proteins that perform distinct functions
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in tissue-specific or developmental stage-specific manners. As
estimated by genome-wide studies, human cells have about 20,000
genes in their genome, but produce hundreds of thousands of
distinct proteins. These proteins cannot be encoded in the genome
by individual genes, so RNA alternative splicing provides a
wonderful tool to expand the size of the protein pool and increase
the functional diversity of the cells (Keren et al., 2010). The
sequencing results with the new RNA-seq technique have shown that
there are around 100,000 alternative splicing events in human cells
(Pan et al., 2008). For an example, the Drosophila Dscam gene (Down
syndrome cell adhesion molecule), which encodes axon guidance
receptors, can produce 38016 mRNA isoforms by alternative splicing
to meet its functional requirements in nervous system (Celotto and
Graveley, 2001; Cooper et al., 2009; Olson et al., 2007). During
development, alternative splicing plays operative roles in many
cellular events, such as cell division, cell fate decision and
tissue maturation (Cooper et al., 2009; Hammond and Wood, 2011).
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Figure 1-3. Dynamic changes of splicing complex
Exons are shown as gray boxes and introns are shown as horizontal
lines. The transformations between the complexes are stated in
detail in the text. GU and AG represent 5’ splice site and 3’
splice site respectively. “A” represents branch point site. U1, U2
and U4/U5/U6 represent small nuclear RNA particles. SF1 represents
splicing factor 1. U2AF65 and U2AF35 are U2 snRNP auxillary factors
65 kDa and 35 kDa. Dashed arrows represent the splicing factors
that leave from the complexes.
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Figure 1-4. Alternative RNA splicing patterns
Diagrams showed different kinds of gene structures. Exons are shown
as gray boxes and introns are shown as horizontal lines. Boxes with
different shaded pattern represent alternatively selected exons.
Splicing patterns are shown as the angled lines above and below the
gene structures. Thickened line in the last diagram represents the
retained intron.
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However within complex genomes containing multi-intron genes,
the limited consensus splice site sequences mentioned above cannot
alone provide sufficient information to distinguish exons from
introns. For instance, many exons with tissue specificity contain
relatively weaker splice sites that are difficult for splicing
factors to recognize (Berget, 1995). Also pseudo-splice sites
within the introns will compete for splicing factors with those
genuine ones (Zhang et al., 2005). Therefore the challenge for
alternative splicing is to determine which splice sites should be
used. Since it is critical to accurately define exons and remove
introns, this process is undoubtedly highly regulated. Fortunately,
other elements around splice sites are available and hundreds of
regulators have been found to bind these elements to play either
positive or negative roles that assist core factors of splicing
machinery to make the right choices of splice sites.

2. Splicing regulators and cis elements
Besides core components of splicing complexes, hundreds of
splicing regulators are required to make sure of the correct
outcomes of alternative splicing. Generally, based on their roles
on making decisions, splicing regulators could be regarded as
either splicing activators or splicing repressors. If the factors
function to promote recognition of certain splice sites, these
factors are called splicing activators. On the contrary, if the
regulators function to make splice sites less recognized, these
factors are splicing repressors.
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2.1 Splicing activators and positive regulation
Splicing activators are factors that can promote recognition
of splice sites. Among the activators, SR (serine and arginine
rich) proteins represent a well-studied activator family that
functions most of the time to promote RNA splicing (Figure 1-5).
They share some common features such as containing one RS (arginine
and serine rich) domain in the C terminus, and one or two RRM (RNA
recognition motif) domains in the N terminus. RS domain usually
consists of RS-dipeptide repeats instead of randomly distributed
arginine and serine. It is the target for post-translational
modifications, and it also mediates protein-protein interactions
(Wang et al., 1998; Xiao and Manley, 1997). The phosphorylation
status will affect SR protein activities (Cao et al., 1997; Du et
al., 1998), and also is responsible for protein shuttling between
the nucleus and cytoplasm, contributing to their subcellular
localization (Caceres et al., 1997). The RRM domains are mainly
responsible for recognizing and binding RNA elements (Bourgeois et
al., 2004), but in some cases, the RRM is also known to be involved
in protein-protein interactions (Cho et al., 2011).
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Figure 1-5. Domain structures of SR splicing factors

SR splicing family contains RS domains in their carboxyl terminus
and one or two RRM in the amino terminus. RRM=RNA Recognition
Motif, RS=arginine serine rich domain. Zn=zinc knuckle. Thin lines
represent linking regions between the domains.
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Figure 1-6. Sequences of exonic splicing enhancers

An exon is shown as the gray box. Thin lines represent the intron
regions flanking the exon. The yellow box within the exon
represents an exonic splicing enhancer. Individual recognition
sequences of splicing factors are shown after the protein names.
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The RNA elements bound by SR proteins are usually located
within exons, called exonic splicing enhancer (ESE)(Figure 1-6).
The enhancers recognized by SR proteins are either purine rich or
pyrimidine rich (Cavaloc et al., 1999; Graveley, 2000; Schaal and
Maniatis, 1999). Although different SR proteins each have
individual binding site preferences, their recognition sites are
highly degenerate (Liu et al., 1998; Sanford et al., 2009). This
degeneracy of binding sites might contribute to the functional
redundancy of SR proteins (Bourgeois et al., 2004; Graveley, 2000).
It has been found that the binding sites of SR proteins are
highly enriched in exons compared with introns (Witten and Ule,
2011). It is believed that binding to the enhancer elements will
help define the exon and facilitate preliminary spliceosome
formation. A well-known example is from the alternative splicing of
doublesex (dsx) pre-mRNA in Drosophila (Heinrichs et al., 1998;
Inoue et al., 1992; Ryner and Baker, 1991)(Figure 1-7). The dsx
gene is a key regulator for Drosophila’s somatic sexual
differentiation. In male flies, dsx pre-mRNA is spliced in a
default way in which exon 3 is joined to exon 5 with exon 4 being
skipped (Nagoshi et al., 1988; Salz, 2011). However in females,
exon 4 is recognized due to the activity of complexes formed on its
exonic splicing enhancer which contains six 13-nucleuotide repeats
that bind Transformer (Tra) and Transformer 2 (Tra2) as well as
Rbp1 and perhaps other SR proteins. Transformer (Tra) is a splicing
factor expressed only in female flies, while the other factors
including Tra2 and Rbp1 are non-sex-specific in the Drosophila
soma. The formation of this complex on the ESE can promote
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recognition of the weak 3’ splice site of exon 4 by facilitating
the binding of the U2AF large subunit U2AF50 through interactions
between the RS domains. Such interactions commit the intron to prespliceosome complex formation (Heinrichs and Baker, 1995; Inoue et
al., 1992; Tian and Maniatis, 1993; Venables et al., 2012). Similar
activity was also been observed in the regulation of the female
specific 5’ splice site of another RNA substrate fruitless within
the Drosophila nervous system, although the precise mechanism of
activation has not been defined. (Heinrichs et al., 1998; Venables
et al., 2012). Also studies of the dsx enhancers showed that the
effect of each repeat on the splicing is additive instead of
synergistic. This suggests that multiple SR-enhancer complexes
increase the probability of a productive interaction between an
enhancer complex and components of the spliceosome (Hertel and
Maniatis, 1998).
The functions of RS domains are not limited to direct
interactions with pre-spliceosomal proteins such as U2AF. Through
secondary contacts with RNA sequence near the splice site itself,
RS domains were also shown to stimulate RNA splicing in a distinct
manner (Shen et al., 2004). When the RS domains were tethered to
exon sequences, they were detected to also make contact with the
branchpoint and promote spliceosome formation. The contact between
the RS domain and the branchpoint was proposed to be relatively
stable compared with the transient unstable interactions with other
RNA sequences. This interaction is thought to facilitate the RNA
base-paring between the U2 snRNA and pre-mRNA sequences at this
site, or to prevent the association of inhibitory splicing factors
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(Shen et al., 2004). The relative in vivo contributions to splicing
activation of protein-protein interactions involving RS domains and
those of RS-RNA interactions remains unclear.
Besides SR proteins, some other factors are also found to
promote splicing by binding to exonic splicing enhancers. For
example, YB-1, originally known as a DNA binding transcriptional
factor, was shown to bind an AC-rich exonic enhancer to promote
exon v4 recognition during the alternative splicing of CD44 in
humans (Coulter et al., 1997; Stickeler et al., 2001).
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Figure 1-7. Alternative splicing of doublesex pre-mRNA
Splicing factors Transformer (Tra), Transformer 2 (Tra2) and

another SR protein are assembled on the exonic splicing enhancer of
exon 4, and help recruit U2AF and recognize the female specific
weak 3’ splice site. The angled line represents the female specific
splicing between exon 3 and exon 4. The dashed angled line
represents the male-type splicing between exon 3 and exon 5.
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2.2 Splicing repressors and negative regulation
Splicing repressors are those factors that can inhibit splice
site recognition and consequently cause exon skipping or intron
retention in the final mature mRNAs. These factors could repress
splicing by binding to either exons or introns to interfere with
early or late steps in the assembly of active splicing complexes.
To exemplify typical mechanisms that are used by splicing factors
to repress splicing I will describe several well-studied systems
below.
First, splicing repressors can interfere with the primary
recognition of splicing signals in pre-mRNAs. As discussed above,
basic splicing signals include 5’ splice site, 3’ splice site,
polypyrimidine tract and branch point. It was shown that hnRNP A/B
could bind to an exonic splicing silencer of the vpr exon in HIV-1
pre-mRNA, nucleate more hnRNP A/B binding upstream of the silencer,
and repress the exon splicing by competing the activity of U2AF65
in the upstream polypyrimidine tract (Domsic et al., 2003). Also in
Drosophila, Sex-lethal (Sxl) represses the male specific exon
splicing of tra pre-mRNA by binding the polypyrimidine tract of the
male-specific 3' splice site and blocking the essential splicing
factor U2AF65 in this site (Valcarcel et al., 1993)(Figure 1-8A).
Other splicing repressors are known to compete and antagonize
the functions of splicing activators. For example, In HIV I tat
exon 2, hnRNP A1 was shown to bind in the exonic spicing silencer
which is overlapping with another exonic splicing enhancer
recognized by the splicing activator SC35. It is thought that hnRNP
A1 represses tat exon 2 inclusion by directly competing out SC35’s
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activity within the exon. Mutation of the hnRNP A1 binding site in
the ESS will bring back the efficient splicing that is promoted by
the binding of SC35 with high affinity (Zahler, 2003)(Figure 1-8B).
In some cases splicing repressors could form a loop structure
in the pre-mRNA and exclude the regulated exon from the active
splicing complex. This kind of regulatory behavior is observed in
several hnRNP family members. Splicing factors bind the sequences
in both the upstream and downstream introns flanking the regulated
exon. Then the proteins will interact with each other, loop out the
middle exon, and cause the exon skipping. In this way hnRNP A1
promotes exon skipping in its own pre-mRNA (Black, 2003; Blanchette
and Chabot, 1999; Rooke et al., 2003). Similar mechanism has been
suggested to be responsible for the splicing of the c-src N1 exon
regulated by PTB and hnRNP F/H complex in neuronal cells (Rooke et
al., 2003)(Figure 1-8C).
Still another proposed negative mechanism involves the
interference with specific steps in active spliceosome assembly.
During spliceosome assembly, new factors will join the complex and
some factors will leave at the same time. The spliceosome will
undergo a number of conformation changes between E complex and B
complex until it becomes catalytically active. Some splicing
repressors act by disrupting the intermediates in this process
resulting in the formation of inactive complexes that cannot
progress to a catalytically active state. For example, RBM5 was
reported to stall the spliceosome transition after complex A
formation by blocking the incorporation of U4/U5/U6 tri-snRNP into
complex A formed on intron 5 and intron 6. In this way, RBM5
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promotes exon 6 skipping in Fas substrate (Bonnal et al.,
2008)(Figure 1-8D).
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Figure 1-8. Models of splicing repression
(A) hnRNP A/B competes with U2AF65 to bind the polypyrimidine tract
within the 3’ region of the intron, causing 3’ splice site less
recognized. Sex lethal (Sxl) competes with U2AF65 to associate with
the 3’ region and prevent more mature splicing complexes from
forming. (B) The exonic splicing silencer (ESS) overlappes with an
exonic splicing enhancer. Binding of hnRNP A1 to the ESS will
compete with SC35, which associates with the same site within the
exon. (C) hnRNP A1 binds both upstream and downstream of the
regulated exon. The self-interactions between hnRNP A1 molecules
loop out the middle exon and cause its splicing repression. (D)
RBM5 prevents the U4/U5/U6 tri-snRNPs from entering complex A
formed in intron 5 and intron 6, causing the exon 6 skipping.
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3. Position dependent effects of splicing regulators
When the hnRNP family factors such as hnRNP A/B, hnRNP A1 and
PTB were first found to regulate alternative splicing, they were
identified as splicing repressors (Caputi et al., 1999; Mayeda and
Krainer, 1992; Singh et al., 1995). Follow-up studies also proved
time and time again that these factors are mostly involved in the
splicing repression (Han et al., 2010; Spellman and Smith, 2006).
SR proteins were initially identified as splicing activators
(Zahler et al., 1992). And their positive roles on alternative
splicing are also been verified repeatedly in extensive studies on
their mechanisms of actions (Bourgeois et al., 2004; Graveley,
2000). Therefore there is an impression that hnRNP factors can
generally be regarded as splicing repressors while SR protein
family should be an important class of splicing activators.
However, these observations are not universal and a number of
exceptions to this general categorization have come to light. In
some cases it has been found that hnRNP family proteins can promote
splice site recognition, while SR proteins also have the ability of
directly repressing the recognition and utilization of specific
splice sites.
One example of this is provided by the hnRNP H protein which
is known to be a component of splicing enhancer complex binding
downstream of c-src alternative exon N1. Activation by hnRNP H
occurs when it forms a heterodimer with hnRNP F to promote the N1
inclusion in neurons by cooperating with SR proteins and a neural
specific PTB within an enhancer complex (Chou et al., 1999). An in
vitro study with a larger intron also showed that hnRNP A can

	
  

23	
  

stimulate intron splicing with the cooperation of hnRNP H by
promoting an intron definition (Martinez-Contreras et al., 2006).
These exceptional cases could be restricted to particular
substrates or interacting factors. However, is it possible that a
general principle hiding behind these observations could explain
the positive or negative functions performed by the same family of
splicing regulators? With more and more exceptions discovered, the
protein binding location is emerging as an important factor in
determining whether the activation or repression of splicing is
observed from a given regulator.
With the development of the technique of RNA-seq, genome-wide
studies on the alternative splicing by individual regulators has
become possible. Several important splicing factors in nervous
system development have been studied in humans and their binding
targets have been explored at the transcriptome scale (Jensen and
Darnell, 2008; Ule et al., 2003). In such studies all alternative
splicing events were identified, and the effects of mutations in
splicing regulators on the alternative splicing were compared. By
combining transcriptome sequence with in vivo RNA-protein
crosslinking and immunoprecipitation it was found that when Fox1/2
bound the downstream intron of an alternatively spliced exon, it
could promote the exon’s inclusion, while binding in the upstream
intron will cause the exon’s skipping. The protein location
determines its role during the RNA splicing (Zhang et al., 2008).
Similar effects were also observed in other splicing factors like
NOVA and some hnRNP family members (Dredge and Darnell, 2003; Ule
et al., 2006)(Figure 1-9).
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Models have been proposed to explain how the binding locations
may be responsible for different splicing consequences (Witten and
Ule, 2011). When RBPs (RNA binding proteins) bind upstream of the
alternatively spliced exon, they interfere with the recognition of
splice signals in the upstream intron and cause the exon’s skipping
(Chen and Manley, 2009). Fox-1 was shown to repress the splicing of
exon 4 of the calcitonin/CGRP pre-mRNA by binding a UIF (upstream
intronic flanking) region, blocking SF1 from binding the branch
point nearby, and finally preventing E complex formation (Zhou and
Lou, 2008). When binding to the downstream intron, RBPs help to
bridge splice sites and promote splicing (Chen and Manley, 2009;
Licatalosi and Darnell, 2010). In a study of the alternative
splicing of a cassette exon N30 in NMHC (nonmuscle myosin heavy
chain) II-B pre-mRNA, another Fox family factor, Fox-3, was found
to activate N30 inclusion through binding an element within the
downstream intron (Kim et al., 2011). More interestingly, the
active function of Fox is dependent on another splicing factor PSF
(protein-associated splicing factor) in this substrate (Kim et al.,
2011). This suggests that the position-dependent regulation of
splicing by Fox protein is involved with another layer of
regulation and might also be determined by the interactions between
splicing regulators. In some cases, Fox and Nova could regulate the
same substrate synergistically (Zhang et al., 2010). Fox2 was found
to bind the 5’ end of intron 9 from Gabrg2 pre-mRNA, while Nova
bound to the region 3’ of it. It was supposed that by interacting
with each other, Fox2 and Nova looped out intron 9 and promoted
exon 9 splicing in humans (Zhang et al., 2010). Even though more
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details of these mechanisms need to be clarified, these studies
have clearly shown the importance of the binding locations of RNA
binding proteins in terms of the regulation of alternative
splicing.
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Figure 1-9. Position dependence of splicing regulation

Gene structure is shown with gray boxes and horizontal lines, which
represent the exons and introns respectively. Middle darker box
represents a regulated exon. When splicing factors bind downstream
of the alternatively spliced exon, they will help the exon
inclusion. While binding upstream of the exon, they will favor the
exon’s skipping.
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4. Splicing repression by SR proteins
Studies on several pre-mRNAs have revealed the roles for SR
splicing factors in the negative regulation of alternative
splicing. An example is from studies on the role of SF2/ASF in the
splicing of adenovirus IIIa transcript (Figure 1-10). In the early
stage of infection, SF2 could bind the element within the intron of
the exon IIIa and represses the recognition of the distal 3’ splice
site, resulting in the inclusion of a longer exon in early viral
mRNA (Kanopka et al., 1996; Simard and Chabot, 2002). Another case
is related with SRp30c, which is shown to bind an intronic splicing
silencer CE9 of intron 7B in hnRNP A1 pre-mRNA, which causes less
recognition of the downstream 3’ splice site, and finally in the
skipping of exon 7B (Simard and Chabot, 2002). In CFTR substrate,
the SR proteins SRp40 and SF2/ASF form a complex on an intronic
splicing silencer in intron 9, repress the recognition of upstream
exon 9 and cause its skipping (Buratti et al., 2007) (Figure 1-14).
All of these cases share a common feature that SR proteins repress
RNA splicing by binding to the intronic sequences.
How do SR proteins repress the RNA splicing? Some SR proteins
appear to have intrinsic activities that results in the general
repression of splicing. SRp38, a mammalian specific SR protein, can
repress pre-mRNA splicing in a cell cycle dependent way (Shin and
Manley, 2002). Its effect on splicing can be switched from
repressive into active by its phosphorylation status (Feng et al.,
2008). However SRp38 differs from other SR proteins in that it does
not act as a general splicing activator. Even in S100 extract, a
cell free system which is absent of SR proteins but with most other
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splicing components, SRp38 did not activate splicing as other SR
proteins did (Feng et al., 2008). Another SR protein SRrp86 was
shown to repress splicing by interacting and interfering with the
active functions of other SR proteins such as SC35, ASF/SF2 and
SRp55 (Barnard et al., 2002).
Some biochemical properties of these factors also provide
clues. Unlike other SR proteins, SRp38 contains two RS domains in
the C terminus. Both of these RS domains perform repressive
activities. However the repression by RS1 alone is
dephosphorylation-dependent and this domain has only modest
activation function. The second RS domain RS2, containing some SK
dipeptides, displayed a novel second-step repression but without
dephosphorylation-dependent repression and activation ability (Shin
et al., 2005). The SRp38 RNA binding domain (RBD) shows more
similarity with the RRMs of U2AF homology motif family (UHM) rather
than the canonical RNA binding motifs in other SR proteins. This
UHM-like RBD has no activation function, but can prevent the RS1
domain from functioning with positive activity. SRrp86 also contain
an EK-rich domain which is believed to be responsible for its
negative activity in RNA splicing (Li et al., 2002). SF2/ASF
contains two RRMs at its N terminus, as do several other SR
factors. The second RRM is atypical in sequence and was shown to be
critical for its repressive activity in the splicing of Adenovirus
IIIa (Dauksaite and Akusjarvi, 2002). This function seems to depend
on a conserved “SWQDLKD” motif in the second RRM which was shown in
tethering experiments to perform an effector function necessary for
splicing repression (Dauksaite and Akusjarvi, 2002).
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Figure 1-10. ASF/SF2 represses the distal 3’ splice site
recognition
The adenovirus pre-mRNA structure is shown. The angled lines

represent the splicing patterns. Without SF2, the distal 3’ splice
site will be recognized. When SF2 is present, it will associate
with the splicing silencer in the intron and repress the
recognition of the distal 3’ splice site. E represents the intronic
element.
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4.1 Negative auto-regulation of transformer 2 splicing
Transformer 2 is a Drosophila SR-related protein. As I
discussed above, it is well-known for its positive regulatory
function in doublesex (dsx) alternative splicing where it plays an
essential role for the formation of splicing enhancer complexes and
for promoting recognition of a weak female specific 3’ splice site.
Besides its positive function, Tra2 was found to be
responsible for the retention of the M1 intron in Tra2 transcripts
produced in growing spermatocytes (Mattox and Baker, 1991; Mattox
et al., 1996; Mattox et al., 1990). The M1 intron is alternatively
spliced in the male germline, and the resulting mRNAs encode
different Tra2 protein isoforms (Figure 1-11). The mature mRNA
without the M1 intron will use the start codon located at the
junction of exon 3 and exon 4, therefore it will be translated into
a 226-amino acid peptides called Tra2-PC. In mRNA where the M1
intron is retained this start codon is split and a downstream start
codon within exon 4 has to be used to produce a 179-amino acid
peptides called Tra2-PE (Mattox et al., 1996). In wild type germ
cells about 50% of mature mRNAs retain the M1 intron, but in the
absence of Tra2 function, the intron is efficiently removed from
germline transcripts and the M1 retaining transcripts were not
detected. Other introns in the RNA are unaffected by the presence
or absence of Tra2 function (Mattox and Baker, 1991). Genetic
studies have shown that Tra2-PC is both required and sufficient for
M1 retention in the germline (Mattox et al., 1996). Experiments in
which negative auto-regulation was blocked by the deletion of the
M1 intron showed that this mechanism served to prevent high-level
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expression of Tra2 that would block normal spermatogenesis
(McGuffin et al., 1998).
In vitro studies have identified several cis-acting elements
involved in the M1 splicing (Chandler et al., 2003; Qi et al.,
2007). An intronic splicing silencer (ISS) located upstream of the
branch point was shown to bind Tra2 and was able to mediate the
repression of intron splicing in vitro when it was inserted into
the otherwise unregulated ftz intron (Figure 1-12).
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Figure 1-11. Alternative splicing of transformer 2 pre-mRNA
Transformer 2 gene structure is shown. The gray boxes represent the
exons and the horizontal line represents the M1 intron. The
transcriptional start site is indicated. Two start codons and the
stop codon are labeled above the exons. The first start codon is
split by M1 intron. Protein products from two mRNA isoforms are
shown at the bottom. The mRNA using the first start codon encodes
Tra2-PC containing 226 amino acids, while the M1 retained mRNA
encodes Tra2-PE with 179 amino acids. Tra2-PC is able to repress M1
intron splicing in an auto-regulated manner.
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Figure 1-12. The intronic splicing silencer of M1 intron
A section of the tra2 pre-mRNA is shown. The horizontal line
represents the whole M1 intron. The Black bar represents the

intronic splicing silencer. Red bars represent the binding repeats
of Tra2 protein within the ISS. The whole ISS sequence is shown
below the diagram. Red letters are the CAAGR (R=A/G) repeats
recognized by Tra2. The blue “A” is the predicted branch point
site.
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4.2 Position-dependent splicing repression by SR proteins?
As I discussed in section 3, it is found that in a genome-wide
scale, hnRNP family and other RNA binding proteins exhibit
position-dependent effects on regulating alternative splicing.
A similar situation has also been observed for SR proteins.
Taking the adenovirus IIIa pre-mRNA as an example (Kanopka et al.,
1996), when the 3RE element bound by SF2/ASF within the upstream
intron was moved into the downstream exon, it could be used as an
splicing enhancer to promote exon splicing by the same SR protein
ASF/SF2. The ISS element in CFTR intron 9 was also found to exert
an exonic enhancer function when it was moved to an exon (Buratti
et al., 2007). A systematic study of this issue is found in work on
Drosophila transformer 2 (Qi et al., 2007). The ISS element was
found to contain five CAAGR repeats that bind Tra2 protein and are
necessary for splicing repression to occur. These repeats are
located upstream of the branch point but also mediated repression
from distant intronic positions. This suggests that Tra2-ISS
complex does not act to simply block the splicing signals, but
instead represses through other interactions. Interestingly
Tra2/ISS interactions could exhibit splicing enhancer activity when
the ISS was inserted into the dsx exon (Shen and Mattox, 2012).
Further, using an MS2 protein tethering assay (Shen and Mattox,
2012), Tra2 was found to perform a similar repressive function when
it was tethered at different positions within the ftz intron, but
activated splicing when tethered in dsx exon 4 or an exon in a ftz
RNA substrate. These observations also suggest that the opposite
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effects were not due to the differences between the ISS and ESE but
rather due to the binding positions of the protein (Figure 1-13).
Why does the binding position matter? Why do SR proteins
prefer to repress splicing when they bind within the introns but
promote splicing when they bind in exons? So far no example has
been observed where SR proteins can repress splicing through
binding to an exon. One explanation depends on "exon definition".
Considering the ability of SR proteins to promote splice site
recognition and to recruit U2AF and U1 snRNP to the 3’ and 5’
splice sites, SR proteins could be regarded as “exon definers”.
That is to say that a range of sequences bound by SR proteins will
be defined as belonging to the exon. More intriguingly, if
previously defined intron sequences are bound by SR proteins, this
SR-bound intron part will be “exonized”.
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Figure 1-13. Position dependent regulation of RNA splicing by Tra2
(A) When Tra2 is tethered within the ftz intron, it will cause the
splicing repression and the intron is retained in the final mRNA
product. (B) When Tra2 is tethered in the female specific exon of
dsx, it will promote the exon splicing with no intron remained in
the final mRNAs. MCP-Tra2 is the fusion Tra2 protein with the amino
acids from MS2 coat protein in the N terminus. MS2 BS is the MS2
binding sites shown as stem loops.
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However, this does not explain how “exonizing” of an intron
would cause splicing repression. For instance, in the case of hnRNP
A1 pre-mRNA, SRp30c was known to bind the intron upstream of exon 8
but caused exon 8 skipping instead of inclusion of a longer exon
inclusion (Simard and Chabot, 2002). Another important factor for
consideration is the availability of a splice site nearby. Exon
definition can only make a preliminary decision that the parts SR
protein bound could be a potential exon. But to complete exon
definition, the availability of nearby splice sites outside the
bound region is also necessary. This idea is supported by the
experiments with CFTR RNAs (Buratti et al., 2007)(Figure 1-14).
When the people created a novel 5’ splice site downstream of an ISS
within the intron 9, the resulting spliced products include a new
exon using a pseudo 3’ splice cite just upstream of the ISS.
Interestingly the alternative splicing of adenovirus regulated by
SF2/ASF also suggested a similar mechanism in which the intronic
part containing the ISS was exonized. And there was a 3’ splice
site available just upstream of the SR binding sites, consequently
the final mRNA contained a longer terminal exon 5265K (Kanopka et
al., 1996)(Figure 1-10). If no splice site is available around the
SR binding sites, the exon will be skipped or the intron will be
retained. When Tra2 binds to the ISS element in the M1 intron, it
helps define the intron part as an exon. However in this case no 3’
splice site is present upstream of the ISS within M1, and so the
direct consequence is the retention of the intron.
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Figure 1-14. Splicing regulation of CFTR pre-mRNA

The exons and introns of partial CFTR pre-mRNA are shown as gray
boxes and horizontal lines. The angled lines represent splicing
patterns. When SF2 and SRp40 bind to the intron 9, they repressed
exon 9 splicing. However when a new 5’ splice sites was created
around their binding sites, a new exon will be defined and included
by using an upstream cryptic 3’ splice site.
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To further test the idea, it would be interesting to see how
the Tra2-induced splicing pattern will change when a 3’ splice site
is created upstream of the ISS within the M1 intron. A logical
prediction is that a smaller intron upstream of the ISS would be
actively spliced in a manner stimulated by Tra2. Exactly this kind
of splicing event occurs in Tra2 transcripts from Drosophila
virilis (Chandler et al., 1997), another Drosophila species that is
about 60 million years diverged from Drosophila melanogaster.
Within the vM1 intron (Drosophila virilis M1 intron), as shown in
figure 1-15, there are several scattered CAAG repeats similar with
the Tra2 binding sites in M1 intron. A 3’ splice site in this case
is available just upstream of the CAAG repeats. Consequently vM1
intron retention could be achieved incompletely with a short
fragment of vM1 intron being cut off (type B mRNA in figure 1-15).
Another similar phenomenon is also seen in the splicing regulation
of a testis-specific exon TLE4 by human Tra2. As shown in figure 116, hnRNP G forms a protein complex with other factors, and help
recognize the exon T with the weak 5’ splice site but a strong 3’
splice site. When the Tra2 level is elevated, it binds to the
repeated sites upstream of the exon T to form a larger complex.
Another weak 3’ splice site is located just upstream of the Tra2
binding sites, resulting in the definition of a longer exon B in
the presence of Tra2 (Liu et al., 2009).
Although this model could explain some repressive phenomena
mediated by SR proteins, we still need to keep in mind that the
final spliced mRNAs are the products of both positive and negative
regulations. Even though we saw the splicing repression by SR
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proteins, it is still possible that other splicing repressors could
bind to other elements and antagonize the positive functions from
SR proteins. For example in the regulation of src pre-mRNA
splicing, SF2/ASF interacts with a negative regulator of splicing
(NRS) to form a repressive complex upstream of the src exon and
causes the skipping of the exon (McNally and McNally, 1996). In
this complex, it is not clear which protein plays a more important
role on the splicing repression. Interacting partners could be
another layer of the splicing regulation by SR proteins, just as
was found in the case of pre-mRNAs regulated by Fox and Nova.

	
  

41	
  

D. virilis tra2 gene!
!"$#
#)#

!"#
#+#

'()#

#%#

A!

#)#

#+# #%#

B!

#)#

#+# #%#

C!

#%#

D!

#%#

E!

#)# #+#

#&#

#&#

#*#

#*#
#*#

#&#
#&#

#&#

!"$#

$#

#*#

#*#
#%#

#&#

#*#

	
  

	
  
Figure 1-15. M1 intron retention in Drosophila virilis
The M1 intron in Drosophila virilis is also regulated by
Transformer 2. The Tra2 gene from D. virilis is shown with gray

boxes and horizontal lines corresponding to the exons and introns
respectively. Red boxes represent the retained part of the vM1
intron. Blue bars represent repeated binding sites for the Tra2
protein. Tra2’s binding to the repeats will repress vM1 intron
splicing resulting in Type C transcripts but it also facilitate
utilization of a 3’ splice site available upstream of the binding
site within the vM1 intron, causing use of a small intron upstream
of the binding region and production of Type B mRNA.
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Figure 1-16. TLE4 alternative splicing regulated by hnRNP G and
Tra2

Without Tra2 overexpression (A), testis-specific exon T is included
by hnRNP G complex with other factors recognizing the weak 5’
splice site. With Tra2 protein level increased (B), a longer exon
is included in the testis by Tra2’s binding to the repeats upstream
of the exon T and recognizing the weak 3’ splice site. Red boxes
indicate the Tra2 binding sites.
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5. RNA splicing and germ line development
As a critical cellular process, alternative splicing is
involved in many developmental events (Kalsotra and Cooper, 2011).
Its disruption can cause developmental defects or diseases
including cancers (David and Manley, 2010). However how alternative
splicing regulates germ cell development has not been extensively
studied and well understood.
As a highly organized system, lots of genes are alternatively
spliced during gametogenesis including those involved in sex
determination, signal transduction and meiosis. Under normal
conditions, some genes have multiple spliced isoforms (Liu et al.,
2011) and some of these isoforms are testis- or ovary- specific
(Chuman et al., 2009; Daniel et al., 2001). There is some evidence
showing that RNA splicing can be used by germ cells as a way of
adapting to external conditions (Daniel et al., 2001). For example,
a mouse gene AchE (acetylcholinesterase) has many variants
differing in its C terminus produced by the alternative splicing. A
splicing variant AchE-R was reported to interact with RACK-1
(receptor of activated protein kinase C) and probably induced
apoptosis in germ cells under stressful conditions. AchE-R is also
able to interact with enolase and elevate sperm motility by
increasing its metabolism (Mor et al., 2008).
Defects in splicing are also associated with human
infertility. It is known that splicing defect due to the mutations
in intron 9 of Wilm’s tumor gene 1 (WT1) can cause decreased
expression level of SRY and SOX9, which is responsible for Frasier
syndrome (Schumacher et al., 2008). Also a point mutation in the
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splice acceptor site of intron 10 of LH receptor gene is reported
to be responsible for male hypogonadism (Bruysters et al., 2008).
In Drosophila, a defect in the splicing of Dic61B, a dynein
intermediate chain gene, can cause abnormal assembly of the sperm
axonemal complex (Fatima, 2011). Although these studies identified
specific splicing defects, they put more emphasis on the aspect of
developmental consequences caused by the impairments of RNA
splicing. But the regulatory mechanisms of those alternative
splicing events have not been elucidated.
Very little is known about how germline alternative splicing
events are regulated. In only a few studies have critical RNA
elements and splicing regulators been identified or their
relationship studied. Human Tra2 has been shown to play roles in
some of these splicing events. For example, human HIPK3
(homeodomain interacting protein kinase 3) is localized in PML
bodies which are related with p53 phosphorylation and apoptosis.
Its testis-specific splicing was regulated by several well-known
splicing regulators, such as hnRNP A1, Tra2, ASF/SF2 (Venables et
al., 2005). ASF/SF2 can form a complex on the testis-specific exon
while Tra2 and hnRNP A1 will compete with each other to access the
complex. When Tra2 was hypophosphorylated, it was found to form a
highly stable complex with SF2 and SRp40, and promote the
recognition of the weak 5’ splice site of the testis-specific exon.
In another substrate TLE4 (Transducin Like Enhancer of split 4)
(Liu et al., 2009), hnRNP G-T and RBMY can bind to a testisspecific exon which is within intron 6 and normally spliced out
with the intron in other tissues, then activate its splicing in
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human testis (Figure 1-16). These studies revealed details of the
mechanisms of alternative splicing events that happen in testis.
However their focus is limited to the regulation of alternative
splicing at the molecular level, with little exploration of how
important these molecular events are for the normal development of
germ cells.

5.1 The role of Tra2 in spermatogenesis
As a splicing regulator that is required for sexual
differentiation in somatic cells, Tra2’s function in testis is also
important. Homozygous mutant tra2 flies are sterile and their
seminal vesicles are empty. Belote showed that Tra2 is required for
normal spermatogenesis (Belote and Baker, 1983). In tra2 mutants,
the spermatid heads were not able to elongate, but formed in a
dense round shape compared with the needle-shaped heads in wild
type (Belote and Baker, 1983). Some preliminary data suggests that
mutant primary spermatocytes underwent a delay in entry to meiosis
but eventually complete normal meiotic divisions (unpublished data,
Unni and Mattox). It is not known if the delay results from changes
in the RNA splicing or if it is responsible for infertility.
Studies on the auto-regulation of Tra2 expression in the
germline suggest that splicing of the M1 intron is required for
normal germ cell development (Mattox et al., 1990). As I discussed
in section 4, this negative autoregulation is believed to limit the
amount of the functional Tra2 isoform, Tra2-PC. That too much Tra2
is also toxic for germ cell development was demonstrated by
deploying a modified system that could escape negative
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autoregulation and elevate Tra2 level in the meantime (Mattox et
al., 1996).
As a well-established model, the study of Tra2 autoregulation
could be very useful to understand the mechanism of alternative
splicing in the germline. More importantly, it will be powerful to
test the effects of splicing events on germ cell development.
Genetic and cytological analysis can be used to characterize the
phenotypes and identify molecular targets downstream of Tra2 in
which RNA splicing may be affected.

6. Goals of this study
Although SR splicing factors have been studied extensively for
many years, their ability to repress splicing has remained obscure
and the mechanisms unclear. As I discussed in section 3, such dual
roles are not limited to SR proteins but are also observed in some
hnRNP splicing family members. And it is now clear that the
positions of regulators binding in relation to splice sites play a
critical role.
The Tra2 protein provides an intriguing example of these dual
roles for its positive role in dsx splicing and the negative role
in M1 intron retention. What is more interesting is that these
opposite activities have also been shown to be position dependent.
The ISS element within M1 intron can mediate Tra2-dependent
activation or repression depending on whether it is positioned in
an exon or an intron (Qi et al., 2007; Shen and Mattox, 2012).
Moreover molecular tethering experiments demonstrate that
activation and repression functions are mediated by distinct and
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separable effector domains of the protein (Shen and Mattox, 2012).
The RS domains of Tra2 are required for the positive splicing
activity that occurs from exonic positions, while the RRM domain is
critical for the negative activity observed from intronic sites.
The RRM domain here is not thought to be used to bind RNA elements
because Tra2 was tethered on RNA by the MS2 coat protein in these
experiments. It is possible that the RRM could interact with some
other proteins to help Tra2 repress M1 intron splicing. Since
different domains are responsible for its distinct regulatory
activities, it will be interesting to know what factors are the
partners of Tra2 and what kind of complexes are formed on the M1
intron to make intron splicing repressed. To explore this novel
activity I will use an RNAi screen to identify potential Tra2 corepressors and characterize their activities during M1 intron
splicing. My work reveals that Half pint, a conserved RNA binding
factor previously described for its role in the positive regulation
of splicing, plays an essential role in the splicing repression by
Tra2.
Negative regulation of splicing by Tra2 is also important
developmentally in the process of spermatogenesis. However the
critical targets of Tra2 regulation in the germline have remained
unclear. Most studies on the role of RNA splicing during
spermatogenesis focused either on the cytological phenotypes and
developmental consequences, without elaboration of the mechanism;
or focused solely on the description of alternative splicing events
without a clear developmental context. It is important to know how
RNA splicing in normal conditions of germ cell development. In
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other words, some detailed questions should be answered like:
Specifically what critical target genes are alternatively spliced?
How are these splicing events are regulated? What stages of germ
cell development are affected by these splicing events? This type
of approach will provide insights into the role of RNA splicing and
spermatogenesis, and understand how the regulation of RNA splicing
itself regulates germ cell development.
In the studies described here I will make use of the genetic
approaches available in Drosophila to investigate how Tra2 and Half
pint affect the alternative splicing of Taf1, a target that plays a
vital role in spermiogenesis. This analysis provides insights into
the role that splicing factors play in the development of the
germline.
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Chapter Two

An RNAi Screen for Factors Required in Tra2-Dependent
Repression of pre-mRNA Splicing

Introduction

The mechanisms responsible for repression of splicing by SR
factors are poorly understood. To shed light on these mechanisms it
is necessary to identify factors that collaborate with SR factors
specifically in the repression but not the activation of splicing.
Transformer 2 provides a classic example of splicing repression by
an SR splicing regulator. It has been found responsible for the
retention of M1 intron in its own pre-mRNA in Drosophila male
germline. Previous studies have focused primarily on cis acting RNA
sequences involved in repression. Several such elements within the
M1 intron and the upstream exon are necessary for Tra2-mediated
splicing repression (Figure 2-1). For example an exonic splicing
enhancer within exon 3 was shown necessary to obtain maximal M1
repression but was not sufficient to confer repressions on other
introns (Chandler et al., 2001). An intronic element close to the
5’ splice site was shown to function as an intronic splicing
enhancer (ISE), which promotes efficient basal M1 splicing in the
soma where repression is not observed in most cell types (Chandler
et al., 2001). More recently an intronic splicing silencer (ISS)
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sufficient to confer Tra2 dependent repression on another intron
was identified (Qi et al., 2007)(Figure 2-2A). This 78 nucleotide
element is located immediately upstream of the predicted branch
point of the intron. Within this ISS, there are five repeats of the
sequence CAAGR that are required for Tra2 binding. In in-vitro
studies, when the intact ISS was inserted into ftz intron, it was
found to be sufficient to repress the intron splicing by Tra2
protein. When these repeats were progressively mutated, both Tra2
binding and the efficiency of repression were diminished in a
manner related to the number of repeats affected (Qi et al., 2007).
The binding of Tra2 was found to inhibit the formation of
spliceosome complex A. The mechanism of M1 retention by Tra2 could
be simply explained if Tra2’s binding to the ISS located upstream
of the branch point physically blocks the access of U2 snRNP to the
pre-mRNA, an essential step in the formation of this complex
(Figure 2-2B). However when the ISS was moved upstream away from
the branch point, about 30 nucleotides distant, it still can
mediate the splicing repression by Tra2 protein (Qi et al., 2007).
That suggests instead of passive occupation of the branch point and
occlusion of U2 snRNP, Tra2 binding with the ISS actually forms a
functional repressive complex that actively interferes with
spliceosome assembly.
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Figure 2-1. Diagram of the regulatory elements within and near M1
intron
The section of tra2 pre-mRNA structure is shown with boxes and
lines, which correspond to exons and intron respectively. Darker
gray box represents the intronic splicing silencer. The green boxes
represent the enhancers within exon 3 and M1 intron. An intronic
splicing enhancer within M1 intron and an exonic enhancer in exon3
contribute to the recognition of the 5’ splice site.
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Figure 2-2. A model for M1 retention mediated by Tra2
(A) The diagram of partial tra2 RNA and ISS element (indicated by
the thick black bar and five red small bars). The ISS sequence is
shown below the diagram with the binding repeats labeled with red
color. The predicted branch point is shown with blue “A”. (B) Tra2
was thought to occupy the ISS element and prevent U2 snRNP from
binding to the branch point site, thus repress functional
spliceosome complex formation.
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This repressive complex is also suggested to be different from
another Tra2-dependent complex that activates dsx splicing in the
soma of Drosophila females. First, Tra2 binding sites are different
in these two complexes. Tra2 binds directly to a TCAACA element
within dsx exon 4 (Lynch and Maniatis, 1996), while it binds to
CAAGR in M1 intron. Second, Transformer (Tra), another key
component in the splicing complex of dsx exon 4, is not needed in
M1 retention, because Tra is expressed only in females. When Tra
was forced expressed in male germline, no effect on M1 splicing was
observed (Chandler and Mattox, unpublished). Third if ISS was
replaced by just CAAGR repeats, most of its repressive function was
lost (Qi et al., 2007), while dsx repeats appeared to function well
without other elements (Hertel and Maniatis, 1998). Fourth, the
active and repressive functions of Tra2 are separable. The RS
domain of the protein has been shown to be the biochemical effector
region responsible for the activation of splicing from exonic
positions, but its RRM acts as the effector of its repressive
activity when bound with an intron, as discussed in Chapter One
(Shen and Mattox, 2012). These observations suggest that distinct
factors collaborate with Tra2 during activation and repression of
splicing and that the repression is likely to depend on one or more
proteins that have not been identified as in classical studies on
dsx activation.
To identify Tra2 co-repressors, we carried out a small-scale
RNAi screen in S2 cells with a luciferase signal-based M1 splicing
reporter. This screen identified several factors that are strong
candidates to function with Tra2 in splicing repression.
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Materials and Methods

Plasmids and primers
pM-Luc (M1 reporter) was constructed based on pBluescript SK+
vector (pSK+). The promoter from actin 5C was amplified and ligated
into pSK+ after KpnI and ApaI digestion. The polyadenylation
element from SV40 was amplified and ligated into pSK+ after SacII
and SacI digestion. A segment of the tra2 pre-mRNA including the
entire M1 intron and flanking exon sequences was amplified and
ligated into pSK+ after ApaI and BamHI digestion. Luciferase coding
sequence was amplified and ligated into pSK+ after BamHI and XbaI
digestion. The primers used are listed below:

actin 5c: 5-ATGCCCTACTAGAAGATGTGT, 3-CTCAAACGGTAGTGATATGAA;
tra2 RNA: 5-TTTCATTTGGATTTGCCCCCT, 3-TTCGCGATCGCGTGATGAACG;
luciferase cDNA: 5-GAAGACGCCAAAAACATAAAG, 3-TTACACGGCGATCTTTCCGCC;
SV40 signal: 5-GATCATAATCAGCCATACCAC, 3-GATCCAGACATGATAAGATAC.

3XFlag Tra2-PC was made by inserting a 3XFlag tag into the N
terminus of the 6XHis Tra2 PC baculovirus expression construct (Qi
et al., 2007). The DNA fragment encoding the 3XFlag tag was
synthesized by Integrated DNA Technologies.

Tra2-PC cDNA was amplified from pFastBac 3XFlag Tra2-PC and then
inserted into pSK+ between the Actin5C promoter and an SV40
polyadenylation signal (pSK-AS).
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pftz-Luc was constructed with the similar way of pM-Luc. The only
difference between these two reporters is that the ftz DNA
containing the ftz intron and flanking exon sequences, was
amplified with ftz primers:
ftz RNA: 5-ATGGACTACTTGGACGTCTACTCG, 3-CTTGATCTGCCTTTCGCTCAG.

RNA interference library
RNAi library was generously provided by Dr. Eric Wagner.
Briefly, the library contains cDNAs of CDS fragments of 247 RNA
binding proteins in Drosophila. The RNAi library is amplified
first, then 10µL PCR products was used as template to synthesize
single strand RNA by in vitro transcription (Ambion T7 MEGAscript
kit). In vitro transcription was performed at 37oC for over night.
1µL DNAseI (NEB company) was added to each well, incubated at 37oC
for 20 minutes. Then 100µL dsRNAs were made by mixing equal volume
of both sense and antisense single strand RNAs in the dsRNA buffer
(100mM NaCl, 20mM Tris-HCl, pH 8.0, 1mM EDTA) heated at 100oC,
cooled down at room temperature for at least 30 minutes, and
finally incubated on ice before use. Both DNA templates from PCR
reactions and RNA products from in vitro transcription were
validated by the gel electrophoresis. The library was stored at 80oC.
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RNAi screen in S2 cells
1X107 S2 cells were seeded within 10cm dishes. 30ug total DNA,
including a Renilla luciferase reporter plasmid as a control for
transfection efficiency, were transfected with 60µL cellfectin
(Invitrogen). After 6-7 hours, fresh medium was changed, cells were
counted and reseeded into 96-well plates with 3X104 cells per well.
1.5µL dsRNAs were added into the wells and the plates were
incubated at 28oC for 72 hours.

Luciferase assay
The medium in each well of RNAi treated cells\ was removed and 20µL
passive lysis buffer (Dual-Luciferase reporter Assay system from
Promega) was added. This mixture was incubated at room temperature
for 15 minutes. Luciferase Assay Reagent II (LAR II) was prepared
by mixing lyophilized Luciferase Assay Substrate with Luciferase
Assay Buffer II. 100µL LAR II was added into each well of 96-well
plates and firefly luciferase activity was measured on a Perkin
Elmer VICTOR™ X5 Multilabel Plate Reader. Then another 100µL
Stop&Glo reagent was added, Firefly signal was quenched and Renilla
luciferase activity was recorded.

Data analysis
Firefly luciferase activity was divided by Renilla luciferase
activity for each sample. This ratio was used for further analysis.
The results of luciferase activities from two independent
experiments were collected and calculated by MA plot method.
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Duplicate results for each well were calculated into two
parameters: M and A. M = log2(N1/N2), which represents the
reproducibility of the RNAi effect in that well. A = 1/2 X log2(N1 X
N2), which represents the average value of luciferase activity in
each well. N1 and N2 represent two values from each time of the
screen. After each well has its own M and A values, they will be
normalized by the M and A values from the negative controls, in
which A value was set as 0(Liu et al., 2007).

	
  

58	
  

Results
1. Validation of a splicing reporter system for the co-repressor
screen
To identify factors that contribute to the Tra2-dependent
repression of M1 splicing we designed a M1 reporter plasmid (pMLuc) in which the expression of firefly luciferase depends on the
splicing of M1 intron (Figure 2-3). The reporter plasmid includes
part of tra2 gene that contains both the intact M1 intron and the
flanking sequences from adjoining exon 3 and exon 4. A naturally
occurring translation initiation codon is split by the M1 intron
and is positioned as the only initiator that is in-frame with the
downstream luciferase coding sequence. Cotransfection of Drosophila
S2 cells with a plasmid expressing the Tra2-PC protein isoform
results in increasing repression of splicing from this reporter and
reduced luciferase levels (Figure 2-4). However, neither splicing
nor luciferase activity from a control reporter (pftz-Luc)
containing a constitutive intron from the ftz gene was repressed by
the expression of Tra2-PC.
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Figure 2-3. Scheme of RNAi screen in S2 cells
The organization of reporter plasmids used to screen for Tra2
cofactors in Drosophila S2 cells is shown.

Splicing of the M1

intron from M1 reporter transcripts leads to expression of firefly
luciferase (Luc). The exons and M1 intron derive from the
endogenous Drosophila Tra2 gene. The initiation codon shown is
naturally split by the intron and is in frame with the luciferase
coding sequences. Construct of pTra2 has the same promoter and poly
A signals with the M1 reporter. Cotransfection of both M1 reporter
and pTra2 into S2 cells will cause minimum luciferase activity
expression. While knockdown of any Tra2 corepressors in cells by
its dsRNA will restore the luciferase signal.
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Figure 2-4. M1 luciferase reporter detects specific repression of
M1 splicing
(A) The luciferase activity from M1 reporter but not ftz reporter
is repressed by the expression of Flag-tagged Tra2-PC in
cotransfection experiments. Results from luciferase assays (graph)
and immunoblots probed with anti-Flag antibodies are shown. The
position of Flag-Tra2 and two nonspecific bands (nc) typically
observed in such assays as well as molecular weight markers are
indicated. (B) The effects Tra2-PC on the splicing of transcripts
from both reporters, as detected by RT-PCR, is also shown. As
expected, the ratio of amplification products from unspliced (U) to
those of spliced (S) transcripts deriving from M1 reporter
increases with higher levels of Tra2-PC.
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This system was next tested for its response to dsRNA
knockdown of Tra2 (Figure 2-5). Treatment with tra2 dsRNA restored
the luciferase activity to nearly the same level as that of the
reporter only. Treatment with U2AF50 dsRNA on the other hand
dramatically lowered reporter activity. Since U2AF50 is a core
basic splicing factor, its decreased level is expected to halt premRNA splicing. This was indicated in Figure 2-5 by the lower
luciferase activity that reflects less spliced transcripts. No
effect was observed when treated with a non-specific control dsRNA
(Figure 2-5). These results indicate that repression of the M1
reporter resulting from introduced Tra2-PC could normally respond
to dsRNA treatments.
This system was further used to carry out a screen with a
dsRNA library that targets a group of 247 drosophila proteins
coding genes with known or potential roles in RNA metabolism (Park
et al., 2004). The screening layout is shown in Figure 2-6. In each
plate there are four kinds of controls included. Positive controls
are the cells transfected with both M1 reporter and Tra2-PC, and
treated with double stranded tra2 RNA, which is synthesized
separately in our lab and distinct with the tra2 dsRNA found within
the library.
From the screen we identified 15 candidate co-repressors that
they had stronger effects on M1 reporter luciferase activities than
the parallel controls treated with tra2 dsRNA.
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Figure 2-5. M1 luciferase reporter responds to dsRNA treatments
The luciferase activity from the M1 reporter is restored from Tra2PC mediated repression by the treatment of tra2 dsRNA. No effect
was observed when treated with the control dsRNA (DSRED dsRNA).
However, even lower luciferase activity was observed when treated
with U2AF50 dsRNA.
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Figure 2-6. The layout of RNAi screen in 96 well plates

The layout of each 96 well plates for RNAi screen is shown. Wells
in the gray middle part are the wells treated with the dsRNAs
targeting 247 Drosophila protein-coding genes with RNA binding
activity. In the wells of left side are the controls without
transfection (C) and reporter only (R). In the wells of right side
are the controls of without (R+T2) and with (dstra2) tra2 dsRNA
treatment.
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2. Results of RNAi screen
The RNAi screen was performed in duplicate. The F/R numbers of
luciferase activities from each well were evaluated using an MA
plot which relates the reproducibility of the results to the
magnitude of change in the reporter activity. The final data is
summarized in the plot shown as Figure 2-7.
In the plot, each dot represents one gene targeted by the
dsRNA in the library. In X axis most dots fell around the value 0,
which suggests most genes’ dsRNAs have no significant effect on the
M1 intron splicing. However all positive controls were found in the
very right part of the X axis with the high A values as expected.
In the Y axis, most dots were also found close to the value 0,
which suggests most dsRNAs gave reproducible results.
By comparing with the mean value of positive controls, about
15 genes were identified that their luciferase activities were
higher than the positive controls when their protein levels were
knocked down by corresponding dsRNAs. Among the identified genes is
tra2 which was blindly detected within the library as a positive
candidate, supporting the reliability of the screen in detecting
positives. The total targets were also arranged in their rank order
of average luciferase activities, as shown in Figure 2-8, that the
lowest is on the left and the highest on the right.
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Figure 2-7. The result of RNAi screen
A library including dsRNAs that are targeting 247 RNA-binding
protein coding genes of Drosophila was screened in duplicate by
using the M1 reporter. Data was summarized in an MA plot.
Candidates were identified with effects similar or greater to that
observed with four of tra2 dsRNA controls (indicated as the red
dots). Activity (A) indicates mean value of luciferase activities.

Reproducibility (M) indicates the difference between log activities
of the luciferase values from the duplicates. All values were
normalized with internal control reporter expressing Renilla
luciferase activity.
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Figure 2-8. Distribution of library genes in the RNAi screen result
The finalized luciferase activities from all target genes in the
library were displayed in the graph with the lowest luciferase
number on the most left, and the highest on the most right.
Positive candidates are listed on the right side of the graph.
Other well-studied splicing factors are indicated by arrows within
the graph. The red line represents the position of the positive
control (dsTra2).
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Among other 14 candidates, 8 of them, including CG4887,
Hfp/Puf68, SF1, CG6418, Iswi, CG6227, CG14641 and Spf45, are all
reported having activities in RNA splicing. CG12493 is a doublestranded RNA binding protein and is known to be required for
Drosophila spermatogenesis. Vas, Dhh1, CG6418 and CG6227 all
contain RNA helicase feature.

3. The validation of candidate co-repressors
To verify the results of the screen, the experiment was
repeated with the identified candidates and negative controls for
another two times using both the 96-well and 24-well plate formats.
The final summarized luciferase results showed that only Hfp/Puf68,
CG4887 and Spf45 had the most significant effects on the repression
of M1 intron (Figure 2-9). No luciferase activity or lower
luciferase activities were observed from the negative control
targets of the screen.
Another way to validate the candidates is to test the effect
of dsRNAs targeting them on the splicing of the M1 reporter. As
shown in figure 2-10, a majority of reporter transcripts were
spliced in the reporter only sample. This pattern was reversed and
unspliced transcripts predominated when a plasmid expressing Tra2PC cotransfected. Treatment with dsRNAs of CG4887, Hfp/Puf68 and
Spf45 respectively decreased unspliced products significantly, as
shown with RT-PCR and qRT-PCR (Figure 2-11). These results verified
the results from the luciferase assay and suggest that these
factors are likely to be co-repressors of Tra2 in M1 intron
splicing.
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Figure 2-9. Validation of the positive candidates
The effects of dsRNAs targeting the positive candidates on the

luciferase activity are summarized in the graph. Significant change
in relation to the control of no dsRNA treatment is indicated (*).
Control dsRNAs from the screen that showed no effect or decreased
effect on the luciferase activity are shown in dark color.
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Figure 2-10. The effects on splicing patterns of M1 reporter by
dsRNAs of candidates
Splicing products from the M1 intron reporter were tested in
various samples treated with the dsRNAs targeting positive
candidates. The effects of the dsRNAs on M1 reporter splicing were
shown in RT-PCR assay. Primer positions are indicated in the
diagram. The mRNA levels of the candidates in S2 cells were also
shown on the right side of the images.
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Figure 2-11. qRT-PCR assay on splicing patterns of M1 reporter by
candidate dsRNAs
Splicing products from the M1 intron reporter were tested in
various samples the same as that used in figure 2-10. The effects
of the dsRNAs on M1 reporter splicing were shown with quantitative
RT-PCR. Primer positions are indicated in the diagram.
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Discussion
Using a small-scale RNA interference screen in S2 cells, I
have identified at least 3 candidate factors that contribute to the
Tra2-dependent repression of M1 intron splicing. To study the
regulation of alternative splicing, people usually choose RT-PCR or
Q-PCR method. However these methods are difficult to adapt to highthroughput screens due to the multiple manipulations required. On
the contrary, a screen based on luciferase signal has been
extensively used and accepted to identify factors involved in a
particular molecular event. It can give real-time results, which
avoids middle steps and also saves time. It is also quite
sensitive, which is very helpful especially for the substrates with
low splicing efficiency. A key feature of this study is the
adaption of the luciferase assay to measure a particular
alternative splicing event. Several previous studies of RNA
splicing have also used splicing reporters based on luciferase
activity. However few of them is based on a natural or specific
splicing event (Gowrishankar and Rao, 2007; Younis et al., 2010).
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Figure 2-12. A model of interactions between UHM and ULM domains
within the pre-spliceosome complex
Splicing factors with UHM and ULM domains recognize basic splicing
signals within the 3’ region of an intron and communicate with each
other by the UHM-ULM interactions, leading to pre-spliceosome
formation and transformation into other splicing complexes. Briefly
the interaction between U2AF50 and SF1 helps form the E complex.
Then the interaction between U2AF50 and SF3b155 of U2 snRNP helps
recruit U2 snRNP into the branch point, thus replace SF1 and
transform the spliceosome to the A complex.
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In this study, I make use of the special start codon split by
the M1 intron in tra2 pre-mRNA. By fusing luciferase protein coding
sequences downstream of exon 4 and in frame with this codon, I
found it is possible to evaluate splicing performance based on
luciferase activity. Thus this reporter is very compatible with a
cell-level screen even in a genome wide scale. It can produce
relatively reliable and quick outcomes telling us which are the
potential candidates. It can narrow down the scale dramatically
with less cost of money and time.
Several candidates identified in this study are known to play
roles in alternative splicing events. Among them, Hfp/Puf68, Spf45
and SF1 share the similarity in that they each contain a U2AF
homologue motif (UHM) thought important in several steps of RNA
splicing. This structural domain is distinct, but related to the
RNA recognition motif found in many RNA binding proteins.
Functionally UHMs are thought to mediate specific protein-protein
interactions, most particularly in proteins with ULM (UHM ligand
motif) sequences. The UHM-ULM interactions play a prominent role in
the formation of prespliceosomal complexes formed near the 3'
splice site (Figure 2-12). For example SF1 binds to the sequence at
the branch point and interacts with U2AF65 bound nearby at the
polypyrimidine tract through the UHM-ULM contacts (Kielkopf et al.,
2004). Further the UHM-ULM interactions occur between SF1 and
SF3b155 as well as the large and small subunits of U2AF. The UHM of
the splicing regulator Spf45 is also reported to be required in the
alternative splicing of FAS pre-mRNA in vivo. The interaction
between UHM of Spf45 and ULM of SF3b155, a component of U2 snRNP,
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competes with the UHM-ULM interaction between U2 snRNP and SF1,
leading to exon 6 skipping (Corsini et al., 2007). Hfp also contain
a UHM domain in its C terminus. Since its human orthologue, PUF60
is known to recognize polypyrimidine tract sequences near the 3’
splice site of some introns, it is suggested to function in
prespliceosome in a similar way as U2AF65 does (Hastings et al.,
2007). A speculative model for the mechanism of M1 intron retention
is that these candidate proteins, by utilizing their UHM domains,
might interfere with the interactions between UHM and ULM domains
in prespliceosome complexes and thus prevent A complex formation
(Figure 2-13).
CG4887 is the Drosophila homologue of RBM5 (RNA binding motif
protein) in mammalian organisms. Its function in Drosophila has not
been studied very much, however as a tumor suppressor, RBM5 has
also been reported to regulate alternative splicing of Fas and cFLIP pre-mRNAs, which are the components in apoptosis pathway
(Bonnal et al., 2008). Common substrates shared by splicing factors
identified in the screen are summarized in Table 2-1. This suggests
that the factors identified from the RNAi screen are probably
functional related and that their shared effects on M1 intron
splicing is not coincidental.
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Table 2-1. The targets regulated and shared by positive candidates
The known targets for each candidate are shown, and common targets
between the candidates are indicated with circles.
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Figure 2-13. A model of splicing repression of M1 intron by
positive candidates
Tra2 interacts with the positive candidates and form a complex on
the ISS element. The cofactors with UHM domain will compete with U2
snRNP to interact with U2AF50 and prevent U2 snRNP from entering
the complex E.
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Other factors identified as possible corepressors correspond
to helicases. CG6418 is annotated as the Drosophila homologue of
DDX42 in mammals and Prp5 in yeast. As an RNA helicase it functions
during the step of U2 snRNP recruitment into spliceosome. CG6227 is
the homologue of DDX46 in mammals and Prp11 in yeast. It is thought
to catalyze the conformational change of U2 snRNP and mediate the
interaction of U1 and U2 snRNPs. Together with other RNA helicase
identified in this screen, it will be interesting to investigate
regulatory roles of RNA helicases during alternative splicing. RNA
helicases are thought to catalyze rearrangement of RNA-RNA
interactions and RNPs remodeling during RNA splicing, however as
core splicing factors, whether they have regulatory roles is not
well studied (Linder and Jankowsky, 2011).

It is interesting to see that a number of well-known splicing
factors had no measured effect on the M1 intron splicing when they
were knocked down, these include SF2 and SC35, as indicated in
Figure 2-9. In previous study (Qi et al., 2007), Rbp1 was
previously found to repress M1 intron splicing in vitro and
observed to bind a sequence within the ISS, but its knockdown
resulted in a decrease rather than an increase of the luciferase
activity, which suggests a positive function instead of repression
on the M1 splicing. Similar effects were observed in both U2AF50
and U2AF38, which is consistent with our understanding that U2AF
factors are essential general splicing factors and usually promote
RNA splicing. B52 is a Drosophila homologue of SRp55 in mammals. It
is an essential splicing factor for Drosophila development (Kraus
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and Lis, 1994). B52 can function together with SF2 in the
regulation of alternative splicing of several substrates (Gabut et
al., 2007). When B52 was knocked down in our system, luciferase
activity became dramatically lower, which suggests B52 can actually
promote M1 intron splicing in normal conditions perhaps due to a
general role in splicing. Interestingly this result is consistent
with previous observation from our lab. In an in vitro splicing
assay, SR protein extract can antagonize Tra2’s repressive function
on M1 splicing. And the dominant component of SR protein extract is
B52 (Qi, unpublished results). If and how B52 might antagonize
Tra2’s activity in M1 splicing is another interesting question to
explore.
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Chapter Three

Half pint is a Co-Repressor of Transformer 2

Introduction
Little is known about factors that collaborate with SR
regulators in the repression of splicing. As described in the
previous section we have used an RNAi based screening strategy to
identify factors required for Tra2 dependent repression by the M1
intron. From a short list of candidates, we identified Half
Pint/Puf68 (heretofore called Half pint, Hfp). Our focus on Hfp,
was motivated by the fact that its mammalian homologue PUF60 is
known to promote the utilization of weak 3’ splice sites and has
been implicated in the control of alternative splicing. In
addition, Hfp itself was reported to regulate the alternative
splicing of several mRNAs in the Drosophila female germline (Van
Buskirk and Schupbach, 2002). Notably, Hfp and PUF60 (also known as
FIR) are multifunctional proteins that are known to act as
transcriptional factors. PUF60 is also called FIR (FBP interacting
repressor) and negatively regulates c-myc gene expression (Liu et
al., 2000) through interactions with its far upstream sequence
elements (FUSE). Independently PUF60 was identified as a splicing
factor based on its function in recognition of the 3’ splice site
(Page-McCaw et al., 1999). PUF60 also can function redundantly and
sometime cooperatively with U2AF65 to regulate weak 3’ splice site
recognition (Hastings et al., 2007).
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Hfp also has similarity with proteins in UHM domain family of
splicing factors (Kielkopf et al., 2004). The UHM domain has been
found in several splicing factors including U2AF65, U2 snRNP
subunit SF3b155, SF1 and Spf45. It is structurally like an RNA
recognition motif but diverges in its RNP2 segment of the RRM.
Instead of binding RNA, however, UHM domains are functionally
suggested to be involved in protein-protein interactions. The
interacting part of UHM domain is known as ULM domain. This domain
features tyronine residues and is found in U2AF35 and U2 snRNP
subunit SF3b155. The UHM-ULM domain interactions between several
factors are thought to promote and stabilize pre-spliceosome
complex assembly (Kielkopf et al., 2004).
Here I show that Hfp, which was regarded as a positive
splicing regulator previously (Hastings et al., 2007; Page-McCaw et
al., 1999), is able to help Tra2 repress M1 intron splicing in both
Drosophila S2 cells and testis. Further I show the Hfp gene
expresses two distinct protein isoforms that differ in their
ability to repress M1 intron splicing.
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Materials and Methods

Plasmids and primers
The M1 luciferase splicing reporter, Tra2-PC vector and ftz
luciferase reporter are the same as used in Chapter Two.

pftz-ISS-Luc, pftz-mhc-Luc and pftz-ISS-mhc-Luc are all modified
based on the pftz-Luc reporter. ftz-ISS sequence was amplified from
pftz120 (Qi et al., 2007) and ligated into pftz-Luc by ApaI and
XhoI digestion. pftz-mhc-Luc was made by three steps of PCR with
mhc 3’ splice site sequence fusing into primers:
ftz RNA forward: 5-ATGGACTACTTGGACGTCTACTCG
mhc 3’ 1 reverse: 5- CTTGTTTGCAAGGGGATAAGTTCAATGGGTTAGCTAATGAGTTTT;
mhc 3’ 2 reverse: 5GTCTGACGGGTGCGTTTCGAGTCTTTGCAATCTTGTTTGCAAGGGGATAAG;
mhc 3’ 3 reverse: 5CTCGAGCTCCAGGGTCTGGTAGCGGGTGTACGTCTGACGGGTGCGTTTCGA.
pftz-ISS-mhc-Luc was made based on pftz-mhc-Luc with similar steps.
Only the first step primer is different:
ISS-mhc 3’ 1 reverse: 5CTTGTTTGCAAGGGGATAAGTTCAAAAATAAGATTATCTTGCGGTTCG.

pFlag-Hfp68 was made in the same way as pTra2-PC, which has an
actin 5c promoter and SV40 PA signal sequence. Hfp68 cDNA sequence
was amplified from the plasmid purchased from the Drosophila Genome
Resource Center. Flag sequences was inserted using a PCR based
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strategy. pFlag-Hfp58 was made in the similar strategy with a
different start position in the Hfp coding region.
Hfp68 cDNA forward: 5ATGGACTACAAGGATGACGATGACAAGATGGGAAGCAACGACAGAGC;
Hfp58 cDNA forward: 5ATGGACTACAAGGATGACGATGACAAGATGGAGCAGAGCATCAAGATG.
Hfp cDNA reverse: 5-CTAACCGGACAGATCTCCCTGATC.
HfpΔUHM reverse: 5-CTAGTCCACCGGCCGCATCAGTC.

Cell culture and transfection.
Dmel S2 cells was cultured in SFII-900 medium at 28 degree and
split at regular intervals. When doing transfection, 2X105 cells
were seeded in 24-well plates. Totally 1.5ug DNA was mixed with 3µL
cellfectin in 100µL medium. pSK-AS was used as the DNA carrier.

In vitro synthesis of double-stranded RNA
The procedure for dsRNA synthesis is like described previously
(Park and Graveley, 2005). Briefly cDNA fragments was amplified and
inserted into PCR4 vector (invitrogen). M13 reverse and M13 forward
primers were used to amplify linear DNA template. Then Megascript
T7, T3 and Sp6 kits (Ambion) were used to produce single-stranded
RNAs. Single-strand RNAs were mixed in annealing buffer (100mM
NaCl, 20mM Tris-HCl, pH 8.0, 1mM EDTA), put into 85 degree for 10
minutes and cool down at room temperature for at least 30 minutes,
finally incubated on ice for use.
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tra2 dsRNA primers: forward 5-CGGAATAGAAGTGGATGGTCG, reverse 5TAGTTGCGGAGAGCGTGAAC.
Hfp3’UTR dsRNA primers: forward 5- TTAGAAGGGGGAGCTATCCG,
reverse 5- GAATTGGAAACTATAGTTTA.
Hfp dsRNA primers: forward 5- GGTAGTGCCCACTCTTCCG, reverse 3AAAATGATAGAACAAATGCGGG.

RNA interference assay
dsRNAs were added directly to the medium of SFII-900 with 4µg/well
in 24-well plates, 20µg/well in 6-well pates. To get the maximum
knockdown effect, dsRNA was added two more times in the next 24 and
48 hours points.

Luciferase assay
100µL Passive lysis buffer was added into each well of 24-well
plates. 25µL was used to measure luciferase signal based on the
manual from the Dual-Luciferase reporter assay system of Promega.
And luciferase signals are measured on Perkin Elmer VICTOR™ X5
Multilabel Plate Reader.

RNA immunoprecipitation assay
1X107cells were seeded in 78cm2 dish. Total 30µg DNA were
transfected. After 48 hours, cells were washed two times with 1XPBS
buffer. Then cells were dounced repeatedly in RIP buffer (150mM
NaCl, 50mM Tris pH 7.5, 5mM EDTA and 0.05% NP-40). Cell lysates
were pre-cleaned with Sepharose Gammabind beads (Amersham) for one
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hour. Cell lysates were then incubated with activated beads with or
without conjugated anti-Hfp antibody at 4 degree for 4 hours. After
washing beads for 3 times, the whole precipitates were treated with
Trizol (Invitrogen). RNA isolated from precipitates was analyzed
with RT-PCR.

Western blot
Cell was directly lysed in wells. The primary antibody
concentration is 1:1000 for both anti-hfp antibody and anti-flag
antibody (Sigma M2 monoclonal antibody). Secondary antibody and the
ECL system were from GE company. After incubating one hour at room
temperature, antibodies was washed 10 minutes at room temperature
for three times. Then exposed to film.

RT-PCR
1µg RNA was used to do the reverse transcription following the
manual of Superscript first strand RNA kit from invitrogen.

Real-time PCR
cDNA was synthesized with 1ug RNA total by Superscript first strand
RNA kit. cDNA was mixed with 2X Syber Green PCR mix from ABI.
Primer concentration is 0.625 ng/μL. PCR was performed in following
conditions: 50oC 2 minutes and 95oC 10 minutes, followed by 95oC 15
seconds and 60oC 1 minute for 40 cycles.
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S2 cell immunostaining and image analysis
S2 cells were seeded into 12-well plate with 5X10^5/well
concentration. Coated covers (BD Biocoat) were put into the wells
at the mean time.

Cells were allowed to settle down over night.

Plasmids were transfected next day. After 36-48 hours incubation at
28oC, cell medium was removed. Cells were washed once with 1XPBS,
then fixed with 4% paraformaldehyde in PBS at 37oC for 30 minutes.
After washing with PBS, cells were incubated in PBX (0.2% triton X100 in PBS) at room temperature for 10-15 minutes. Blocking with 1%
BSA at room temperature for one hour, then incubated with first
antibody (1:200 in 1% BSA) at 4oC over night. Wash cells with PBS
four times, then incubate in secondary antibody buffer (1:500 in
1%BSA) at room temperature for 1 hour. After four times washing
step with PBS, take the coverslips out and put upside down onto the
slides with mounting medium. Images were taken with Nikon Eclipse
Ti confocal microscope. Images analyzed for nucleus/cytoplasm
distribution by Imaris 7.3 after deconvolution by AutoQuant X3. The
protein nuclear localization was calculated with the signal in
nucleus divided by that in the whole cell.

Recombinant protein preparation
Full length Hfp68 cDNA was amplified from the vector AT08368
purchased from the Drosophila Genomics Resource Center (DGRC). Full
length U2AF50 cDNA was amplified from whole fly RNA. Both of the
cDNAs were inserted into pET49b+ vector and protein expression was
induced by IPTG in BL21. Protein were purified by Glutathione
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Sepharose (Amersham Pharmacia). 6XHis-Tra2 was expressed and
purified from baculovirus (Qi et al., 2007).

The gel shift assay
Recombinant protein was incubated with 100pmol

32

p-labeled RNA in

the binding buffer (25mM Tris pH 7.5, 25mM NaCl, 1mM EDTA, 0.1mg/mL
tRNA, 0.5mg/mL BSA) at room temperature for 30 minutes. 2µL
reaction product from total 10µL complex was loaded and separated
on the polyacrylamide gel in 0.5 X TBE at 4oC for 3 hours. The gel
was dried and set to exposure.
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Results
1. Hfp is required for the Tra2-dependent repression of M1 intron
splicing in S2 cells
The effect of Hfp dsRNA on the M1 repression was shown in
Chapter 2 (figure 2-10). Knockdown of Hfp was found to dramatically
restore the luciferase activity reduced by overexpression of Tra2PC. The effect on luciferase activity is consistent with a derepression of M1 splicing when Hfp is knocked down. Testing a
second dsRNA targeting Hfp, we found similar effects on the
luciferase activity and verified that levels were significantly
reduced by the dsRNA, as shown by the immunobloting assay with
anti-Hfp antibody. Luciferase expression was restored to over 60%
the level observed in the absence of co-transfected Tra2-PC (Figure
3-1). The result from western blot showed that levels of FlagTra2PC expressed from the transfected cDNA were unaffected by Hfp
knockdown indicating that the effect of Hfp knocking-down on M1
splicing is not due to the indirect effect from a decrease of Tra2
protein level (Figure 3-2). Taken together the above results
indicate that Hfp contributes to the repression of M1 splicing in
S2 cells.
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Figure 3-1. Luciferase activity is restored by Hfp dsRNA in S2
cells
The effect of Hfp dsRNAs on the luciferase activity from S2 cells
transfected with both M1 reporter and Tra2 cDNA is shown. The graph
shows percent luciferase activity in relation to that of the cells
transfected with reporter only. Endogenous Hfp and tubulin protein
levels from the same samples were analyzed with the western blot
displayed below.
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Figure 3-2. The Hfp dsRNA treatment has no effect on Tra2 protein
level in S2 cells
S2 cells were transfected with pTra2 and were treated with Hfp
dsRNA, Tra2 dsRNA and control dsRNA. Western blots detecting the
protein levels of Flag Tra2 and endogenous Hfp are shown.

A

monoclonal anti-Hfp antibody was used to detect Hfp level. The M2
monoclonal anti-Flag antibody was used to detect the transfected
Flag-Tra2.
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2. Hfp associates with tra2 transcripts
The above effects on M1 reporter splicing could potentially
result from indirect effects of other splicing factors that are
regulated by Hfp. To test whether M1 RNA transcripts could
associate with Hfp directly, RNA immunoprecipitation were carried
out in S2 cell lysates with anti-Hfp antibody. RNA sequences from
these precipitates were amplified by RT-PCR with primers inside the
M1 intron and it was found that in comparison to the input signals
a significant fraction of M1 transcripts are associated with Hfp,
but no M1 signal was detected in beads only control (Figure 3-3A).
Notably, the association occured independently of the increased
expression of Tra2-PC indicating either that basal levels of Tra2PC are sufficient to support Hfp binding or that Tra2-PC is not
required.
To further confirm this association and test its specificity,
M1 reporter was cotransfected with same amounts of ftz reporter and
another GFP empty vector containing the same promoter and SV40 poly
A signal (Figure 3-3B). The results showed tra2 M1 transcripts
could be pulled down with the Hfp antibody. However no amplified
products from the other two overexpressed transcripts were detected
in the same precipitate. Together these results suggest that Hfp
affects splicing of the M1 intron through specific associations
with tra2 transcripts.

	
  

93	
  

	
  
	
  

94	
  

	
  
Figure 3-3. Hfp associates with tra2 transcripts in S2 cells
(A) S2 cells were transfected with the M1 reporter, at the same
time with or without pTra2. RNA immunoprecipitation was carried out
to pull down the transcripts with anti-Hfp antibody. RT-PCR assay
detected RNAs precipitated with the Hfp antibody. Primers used are
indicated in the diagrams. 20% input was used as controls. Expected
RNAs were labeled with marker number on the right. In= input,
BO=beads without antibody, BA=beads coupled with antibody. (B) S2
cells were transfected with three reporters of the same amounts.
RNA immunoprecipitation experiment was done the same way as in part
(A). Primers used for RT-PCR were indicated in the diagram.
Association of Hfp with tra2 RNA is not dependent on Tra2 protein.
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3. Both ISS and a weak 3’ splice site are required for the
repression of M1 splicing mediated by Tra2 and Half pint
Hfp was previously known as a splicing activator that is
involved in the regulation of 3’ splice site, however as a
repressor, which elements in M1 RNA will be necessary for its
negative function? Also it is interesting to know whether the
sequences within M1 intron previously found to support the binding
and repression by Tra2 are also sufficient for the repression by
Hfp. Several elements in tra2 pre-mRNA have been reported to be
involved in M1 repression (Chandler et al., 2001; Qi et al., 2007).
Among them, an intronic splicing silencer (ISS) has been identified
in vitro as a functional target of Tra2-PC as discussed in Chapter
One and Introduction. In vivo, it has been shown that a weak 3’
splice site is critical for M1 retention in testis (Chandler et
al., 2001). When the natural 3’ splice site of M1 intron was
substituted with a Drosophila consensus sequence, M1 retention was
abolished. Replacement with another weak 3’ splice site restored
the retention to a wild type level.
As illustrated in figure 3-4, several recombinant luciferase
reporters containing these different elements were made based on
the backbone of ftz pre-mRNA which contains a single intron that is
not normally regulated by Tra2. Notably ftz itself has a strong 3’
splice signal and no significant similarity to the ISS. The weak 3’
splice site from the intron E of myosin heavy chain gene was used
to replace the 3’ splice site of ftz intron in the recombinant
reporters.
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Figure 3-4. Diagrams of luciferase reporters based on ftz gene
backbone

The boxes represent exons and horizontal lines represent introns.
“Luc” is the luciferase cDNA fused in frame with upstream coding
sequence. The M1 intron contains a weak 3’ splice site, while ftz
intron has a strong one. The strong 3’ splice site of ftz intron
was replaced with another weak 3’ splice site from Mhc intron 5 in
the reporters of ftz-Mhc-Luc and ftz-ISS-Mhc-Luc. ISS element is
indicated with a thickened line within M1 intron. It was inserted
into the introns of ftz-ISS-Luc and ftz-ISS-Mhc-Luc. Intronic
sequences close to the 3’ splice sites are listed below each
diagram with red color and italic.	
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To test which elements are sufficient for the M1 repression
mediated by Hfp and Tra2, the luciferase activities from different
reporters were measured. As shown in figure 3-5, only when both ISS
and a weak 3’ splice site were introduced into the ftz intron, the
reporter (ftz-ISS-Mhc) underwent dose-dependent repression by Tra2PC similarly to the M1 reporter. However ftz-based reporters with
only the ISS or the mhc 3’ splice site failed to show repression in
response to elevated Tra2-PC. This confirms that both the ISS and a
weak 3’ splice site are required for the repression mediated by Hfp
and Tra2. Further we verified that the splicing repression of ftzISS-mhc reporter was reversed by the knockdown of Hfp and Tra2 in a
similar manner as found with the M1 reporter. But no effect was
seen with the treatment of the control dsRNA (figure 3-5). Moreover
the knockdown of Hfp led to a similar reversal of both M1 reporter
and ftz-ISS-Mhc reporter when tested in the presence of only
endogenous Tra2 (figure 3-5). To test the possibility that
endogenous Hfp is present in sufficient levels to drive maximal M1
repression, a small amount of Tra2-PC, sufficient to cause a small
increase in the M1 repression, was cotransfected with increasing
amounts of the 68 kD Half pint isoform (Hfp68) (figure 3-6). The
increasing amounts of Hfp68 did not produce further repression of
M1 splicing. This indicates that endogenous Hfp68 levels do not
limit the degree of M1 repression observed. Taken together the
above findings indicate that the repressive function of Hfp on
splicing is specific to some introns that contain certain critical
elements. In this case, both ISS and a weak 3’ splice site are
necessary for the splicing repression of M1 intron by Hfp and Tra2.
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Figure 3-5. Both ISS and a weak 3’ splice site are required for the
splicing repression by Tra2 and Hfp
(A) S2 cells were transfected with reporters and different amounts
of pTra2. The effects of Tra2 on the luciferase activities are
shown in the graph. Percent luciferase activity is in relation to
that of the reporter only. Results with significant change are
indicated (*). Only both ISS and weak 3’ splice site present in the
intron have the similar effect with that of M1 reporter. (B) The
knockdown of endogenous Hfp and transfected Tra2 level restored the
luciferase activities and diminished splicing repression of M1
intron. No effect was observed when treated with the control dsRNA.
(C) Reporters were transfected into S2 cells and treated with both
Hfp dsRNA and tra2 dsRNA. Percent luciferase activity in relation
to that of untreated group is shown in the graph. Significant
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change is indicated (*). Only ftz-ISS-Mhc reporter has the similar
response to the dshfp treatment as the M1 reporter.
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Figure 3-6. Increasing amounts of Hfp68 cannot repress M1 intron
splicing
The luciferase assay carried out after cotransfection with pTra2
and different amounts of Flag-Hfp68. Repression by endogenous Hfp
and transfected Tra2-PC was not augmented by increasing the Hfp68
level.
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4. Half pint antagonizes U2AF50 activity on M1 intron
Initially the binding and functional activity of PUF60, the
mammalian homologue of Hfp, was found to be at the 3’ splice site
of a few introns tested. PUF60 could recognize a relatively weak
polypyrimidine tract that is different from canonical ones
recognized by U2AF65. Our reporter experiments have suggested that
Drosophila Hfp also represses splicing through the 3’ region of M1
intron. To test its relationship with U2AF50 in M1 intron, the
effects of endogenous Hfp and U2AF50 on M1 splicing were measured
with M1 reporter in S2 cells. The knockdown of Hfp increased the
luciferase activity from the M1 splicing reporter by two fold over
that observed without dsRNA (figure 3-7) which is consistent with
our previous results. However a parallel knockdown of U2AF50
resulted in a 2-fold reduction in the activity. Using a splicing
reporter of the ftz intron, no effect was observed when endogenous
Hfp was decreased, but the luciferase activity was again reduced
after the knockdown by U2AF50 dsRNA. These results suggest that
U2AF50 and Hfp have opposite roles in the regulation of M1 intron
splicing.
Considering both U2AF50 and Hfp are splicing factors
associating with the polypyrimidine tract, it is possible that
these two factors compete with each other in this region. To test
this idea, recombinant Hfp and U2AF50 were expressed and purified
from bacteria. As shown in a gel shift assay (figure 3-8), U2AF50
could directly bind to an M1-derived RNA fragment containing both
the polypyrimidine tract and the 3’SS, but Hfp cannot directly bind
by itself under this in vitro conditions. Tested with longer RNA
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substrates, recombinant Hfp only showed weak binding activity with
the full-length M1 intron (figure 3-9). These results suggest that
the recombinant Hfp protein probably requires other proteins to
bind to the M1 intron efficiently.
However when Hfp was incubated together with U2AF50 and M1 3’
splice site, U2AF50 binding signal was decreased in respond to the
increasing Hfp concentrations (figure 3-8). However no extra Hfpassociated signal was observed in these cases, which is consistent
with previous observation that Hfp itself has a very low affinity
with the elements in M1 intron. These in vitro binding assays are
consistent with the findings from splicing reporter assays that
suggest Hfp antagonizes the effect of U2AF50 in the 3’ part of M1
intron.
To test whether any other factors could help Hfp bind M1
transcript, recombinant Hfp was incubated with RNA fragments in S2
nuclear extract. The gel shift assays showed similar decreased
signal of mobility shifted complex with relatively short RNA
elements in response to elevated recombinant Hfp. However
recombinant Hfp promoted a more stable protein-RNA complex when
incubated with the full-length M1 intron in S2 nuclear extract
(figure 3-10). That suggests that the stable association of Hfp and
M1 intron need other sequences within the intron, and other factors
within the S2 nuclear extract might associate with Hfp to form a
more stable complex within the M1 intron.
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Figure 3-7. Hfp and U2AF50 have opposite effects on M1 intron
splicing
S2 cells were transfected with M1 reporter or ftz reporter.
Endogenous hfp and U2AF50 were knocked down by their dsRNAs.
Percent luciferase activity in relation to untreated group is shown
in the graph. Decreased hfp level had no effect on the luciferase
activity of ftz reporter but caused significant increase of
luciferase signal from M1 reporter. Decreasing U2AF50 level reduced
intron splicing in both reporters.
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Figure 3-8. Hfp reduced binding affinity of U2AF50 with tra2 RNAs
(A) U2AF50 and Hfp protein were expressed with GST fusion tag and
purified from bacteria. Tra2 protein was expressed with His tag and
purified from baculovirus. Proteins are incubated together with the
3’ region of tra2 RNA in the binding buffer. The binding complexes
were separated by the gel shift assay. RNA-protein complex and free
RNA are indicated by the arrows and arrowheads. Hfp fusion protein
reduces the amount of U2AF50 associating with RNA target while Tra2
protein does not. (B) Increasing Hfp amount greatly reduced the
association of U2AF50 with tra2 3’ region. Triangle represent
increased Hfp amount within the binding system.
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Figure 3-9. Hfp protein has a higher affinity with the full-length
M1 intron
GST-Hfp was incubated with different lengths of M1 intron fragments
in in-vitro binding conditions. RNA-protein complex was separated
with gel shift assay. The fragments were indicated in the diagram
above the gel images. Hfp-RNA complexes are indicated by the arrows
and free RNA is labeled by the arrowheads.
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Figure 3-10. Hfp disrupted complex formed on short tra2 RNA
fragments
GST-Hfp was incubated with S2 nuclear extracts and different
lengths of tra2 RNA substrates. RNA-protein complexes were
separated with the gel shift assay. Increasing Hfp amount decreased
complex signal on both RNA substrates of tra2 3’ss and ISS-3’ss.
When incubated with the whole M1 intron, the signal of the complex
that S2 nuclear extract formed on the RNA fragment significantly
increased in a hfp dose-dependent manner.	
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5. Half pint is required in vivo for the Tra2-dependent repression
of M1 intron splicing but not for doublesex splicing
The splicing repression of M1 intron is most prominently
observed in the male germline where about 50% of steady state RNA
contains the M1 intron (Mattox and Baker, 1991) and the repression
of splicing is entirely dependent on the presence of Tra2 protein.
To determine if Hfp is also required for M1 repression in vivo we
dissected testes from wild type and half pint mutant adults.
Because strong loss of Hfp function results in lethality at earlier
stages, this analysis was carried out with hypomorphic hfp
mutations that allow adult survival (Van Buskirk and Schupbach,
2002). As shown in Figure 3-11 endogenous M1 splicing efficiency
was significantly increased when half pint function was reduced by
these mutations. Similar effect was seen in different genetic
background of hfp mutants. Also dramatic decrease of M1-containing
mRNAs was seen in the Tra2 mutant. These results demonstrate that
Hfp is required for the repression of M1 splicing in vivo.
Tra2 is also known to activate alternative splice sites when
it is bound to exonic splicing enhancers. To determine if Hfp is
generally required for this activation function we tested whether
female-specific splicing of dsx pre-mRNA is affected in Hfp mutant
adult flies. RT-PCR was carried out on total RNAs with the primers
that detect both the male and female specific dsx transcripts as
diagrammed in Figure 3-11. The results of this experiment, shown in
Figure 3-11 indicate that neither of two different Hfp loss-offunction genotypes reduced the selection of the female specific
splice site that depends on the activation by Tra2. This suggests
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that Hfp is not generally required for all Tra2-dependent
alternative splicing events.
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Figure 3-11. Hfp is required for M1 retention in vivo
RNA prepared from testis of wild type, Hfp mutant and Tra2 mutant
flies were used to do RT-PCR. Primer positions are indicated in the
diagram. Splicing products are shown on the left of the figure. In
wild type testis, M1 retained mRNA is the major product, while in
Hfp hypomorphic mutants, the retention level of M1 intron is
dramatically decreased, which is similar with the effect seen in
the tra2 mutant. Df(hfp)=Df(3L)Ar14-8.
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Figure 3-12. Hfp has no effect on the alternative splicing of
doublesex pre-mRNA
(A) The alternative splicing of doublesex pre-mRNA is shown in the
diagram. Three primers were used to amplify both male and female
products of dsx splicing products and indicated in the diagram. (B)
Whole fly RNA samples from different genetic background were
prepared and used in RT-PCR assay. Compared with the Tra2 mutant,
no male-specific splicing product was observed in Hfp female
mutants.
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6. The N-terminus of Hfp is required for its negative regulatory
function
Analysis of the Drosophila transcriptome indicate that it
contains as many as nine alternatively spliced mRNAs from the hfp
gene (McQuilton et al., 2012)(figure 3-12). These mRNAs are
predicted to encode either of two protein forms that differ by the
presence of a 92 amino acid N-terminal sequence. Type A transcripts
encode a 68 kDa protein (Hfp68) predicted to initiate translation
in the second exon and consistent with the major Hfp product
previously reported (Van Buskirk and Schupbach, 2002). All other
Hfp transcripts contain in frame stop codons a short distance
downstream of this initiation site. However initiation at a
downstream start codon found in these transcripts could potentially
produce a 58 kDa protein.
To study whether these two isoforms differ in their ability to
repress M1 splicing, Hfp isoforms were introduced into S2 cells
with M1 reporter and Tra2-PC. Endogenous Hfp was knocked down by a
dsRNA specifically targeting the 3’UTR of endogenous Hfp (hfp3’UTR
dsRNA). Introduced Hfp isoforms escaped the degradation brought by
the hfp 3’UTR dsRNA since their cDNAs were inserted into the pSK
backbone which contains a distinct SV40 3’UTR sequence. As shown in
figure 3-13, endogenous Hfp was dramatically decreased by the
treatment of hfp3’UTR dsRNA (lane 1 and 2), and the luciferase
signal correspondingly increased to 150% of the level in the
control with no dsRNA treatment. Overexpression of Hfp58 (lane 3
and 4 in figure 3-13) was not able to repress luciferase activity,
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but introducing Hfp68 (lane 5 and 6 figure 3-13) returned the
repression to the similar level of that with no Hfp knockdown. This
phenomenon is also verified by the quantitative RT-PCR experiments
on mRNAs from S2 cells treated in the same way (figure 3-14). The
spliced/unspliced ratio of M1 reporter transcripts was observed to
significantly increase with Hfp knockdown and to be restored after
the expression of Hfp68 but not Hfp58. These results indicate that
only Hfp68 is able to repress M1 intron splicing in S2 cells. Since
the only difference between Hfp68 and Hfp58 lies in the N terminus,
this suggests that the N terminus is critical for Hfp to function
in the repression of M1 intron splicing.
Another interesting part for the Hfp protein is the UHM domain
in the C terminus. Since it is thought to be involved in proteinprotein interactions critical for splicing, we tested its potential
role in the M1 retention. A deletion of the entire UHM from Hfp68
(HfpΔUHM) was made and expressed in S2 cells in the above rescue
assay. As shown in Figure 3-15, overexpressing HfpΔUHM can strongly
repress the restored luciferase signals by hfp 3’UTR dsRNA, as
effectively as did introduced Hfp68. It suggests that the M1
repression by Hfp is likely independent of UHM domain even though
it is thought to mediate the interactions between splicing factors.
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Figure 3-13. Diagram of Hfp mRNA isoforms
The exon-intron patterns giving rise to various Hfp encoding mRNAs

as reported in GBrowse feature of flybase.org. The boxes correspond
to exons, lines to introns. The gray shaded regions are predicted
to be noncoding parts, the orange regions are predicted to be
protein coding. Note that only the RA transcript has the potential
to encode the Hfp68 isoform, all other transcripts are predicted to
encode Hfp58. The transcription direction is indicated by the
arrow.
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Figure 3-14. Hfp58 cannot repress M1 splicing in S2 cells
(A) S2 cells were transfected with the M1 reporter and constructs
expressing Flag-Hfp58 or Flag-Hfp68. Endogenous Hfp was knocked
down by using a dsRNA targeted at its 3'UTR (hfp 3'UTR dsRNA). The
ability of each Hfp isoform to restore repression was tested by the
transfections with expression constructs containing the 3' UTR
sequence from SV40 that are not affected by the dsRNA. Expression
levels of Hfp58 and Hfp68 were detected by western blot shown below
the chart. The 92 kD band shown is a non-specific cross-reacting
protein from the same gel that is used to represent loading. The
effect on M1 splicing was measured by luciferase assay. (B)
Quantitative RT-PCR analysis of total cellular RNA from cells
treated as in (A).

The ratio of spliced/unspliced M1 reporter

transcripts was determined using the primers as shown in the
diagram. Significant change compared with the control treated with
hfp 3’UTR dsRNA only is indicated (*).
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Figure 3-15. The UHM domain of Hfp has no effect on the regulation
of M1 splicing
The role of the conserved C-terminal UHM domain in the splicing
repression was examined using the same approach as in figure 3-14.
A construct in which the UHM domain was deleted from Hfp68
(Hfp∆UHM) was tested for its ability to restore the repression and
found to be nearly identical to the full-length Hfp68. Results that
affected significantly from the control treated with hfp-3’UTR
dsRNA only are indicated (*).
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7. The Hfp58 isoform that lacks N terminus has different
subcellular localization with full-length Hfp68
To investigate why Hfp58 differs in its function from Hfp68,
we tested if it has similar access to the pre-mRNA in cells.
Subcellular localization of both Hfp isoforms were studied in S2
cells by immunostaining with antibodies to both Hfp and the Flag
epitope tag. As shown in figure 3-16, transfected Flag-Hfp68 is
mainly present in the nucleus as indicated by coincidence with DAPI
signal. The same pattern is seen in the staining of endogenous Hfp
with anti-hfp antibody in S2 cells where Hfp68 is the primary
isoform. However Flag-Hfp58 signal was found to divided almost
equally between the nucleus and cytoplasm. These results showed
distinct subcellular localization of hfp isoforms in S2 cells that
is likely to contribute to the observed difference of their
functions in the regulation of M1 splicing.
To quantitate the distribution of these two isoforms we
analyzed multiple confocal images. Green signal representing Hfp
isoforms were collected within both the nucleus and the whole cells
by selecting the 3-dimension space. The percent of Hfp signal in
the nucleus in related to that in the whole cell was summarized in
the graph (figure 3-16 C). Nearly half of the Hfp58 was located
within nucleus while almost all of Hfp68 was contained in nucleus.
These results showed distinct subcellular localization of hfp
isoforms in S2 cells that is likely to contribute to the observed
difference of their functions in the regulation of M1 splicing.
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Figure 3-16. Hfp isoforms have different subcellular localization
in S2 cells
(A) Endogenous Hfp localization (Endo Hfp) detected with anti-hfp
antibody against its C terminal region is shown in comparison to
the localization of Flag-Hfp58 and Flag-Hfp68 in cells transfected
with constructs expressing each form. Anti-Flag antibody was used
to stain transfected Hfp protein. Both Hfp (green) and DAPI
immunfluoescent staining (blue) are overlaid on DIC images of the
same cells in the bottom row. (B) “No transfection” is the control
that both anti-flag antibody and the secondary antibody were used
to stain S2 cells with no transfection performed. “Negative
control” is the control that only the secondary antibody was used
to stain S2 cells with no transfection performed. (C) The
subcellular localizations of Hfp isoforms were analyzed by image
analysis. Flag-Hfp68 and Flag-Hfp58 were transfected into S2 cells
separately. The percent of signal detected within the nucleus as
determined by Imaris 7.3, is shown for both Flag-Hfp58 and FlagHfp68.
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8. Half pint has two isoforms in Drosophila and the expression
pattern shows sexual difference
Even though we found two Hfp isoforms differed in their
behaviors on both the subcellular localization and the ability to
repress M1 splicing in S2 cells, it is still unclear whether they
are both naturally expressed in vivo. We tested this in Drosophila
and in S2 cells by western blot with a monoclonal anti-hfp antibody
that recognizes an epitope in the C-terminus of both Hfp isoforms.
Figure 3-17 shows that two bands were detected in wild type flies
and both are reduced in Hfp deficient mutant. Also both bands are
increased when corresponding cDNAs of hfp isoforms were introduced
into S2 cells (figure 3-17). In the overexposed western blot film
from the experiment in S2 cells (figure 3-17 C), Hfp58 could be
observed and its level was reduced by the treatment of Hfp dsRNA.
More interestingly, Hfp68 is the major isoform in male flies,
but abundant Hfp58 was observed in female flies (figure 3-18). When
exploring their expression pattern in dissected testis and ovary,
Hfp68 was found to be the primary isoform in testis while the major
isoform in ovary is Hfp58. Taken together, these observations
indicate that both isoforms exist in Drosophila and their
expression patterns differs between males and females.
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Figure 3-17. Two Hfp isoforms are expressed in vivo
(A) Western blot showing the comparison of Hfp expression in
lysates from a mixture of Drosophila male and female adult flies
with various genotypes is shown. Both forms are observed in w1118
adults (carrying two wild type alleles of hfp), but are both
reduced in hfp13/Df(hfp). (B) Expression of Hfp68 and Hfp58 in w1118
male (M) and female (F) adult flies is shown as detected by western
blot.

For comparison lysates from S2 cells (S2) and S2 cells

transfected with Flag-Hfp58 (F-Hfp58) were loaded on the same gel.
(C) Both endogenous Hfp isoforms were knocked down by hfp 3’UTR
dsRNA. The image of western blot from figure 3-14A was over exposed
(the middle panel). Hfp58 could be seen under the Hfp68 signal. And
Hfp58 signal showed reduced compared with lane 1 of no dsRNA
treatment.
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Figure 3-18. Sexual difference of the expression patterns of Hfp
isoforms
(A) Western blot of Hfp isoforms in Drosophila with anti-Hfp
antibody. Hfp58 is more abundant in female flies and also is the
dominant form in oocytes compared with Hfp68 in testes. (B) RT-PCR
of M1 intron splicing in Drosophila. M1 is mostly retained in
testis compared with that in oocytes. Primer locations are
indicated in the diagram above the image.
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Discussion

RNA splicing is a complex process that many positive and
negative regulators are involved to make a final splicing decision.
As for SR proteins, they have been studied extensively for its role
on how to promote pre-mRNA splicing. Here we use Drosophila Tra2 as
a model to explore how an SR protein negatively regulates
alternative splicing. The reporter system we used here is designed
for RNAi screening in S2 cells. Since Tra2 represses M1 intron
splicing in testis, it is reasonably to think that there are some
testis specific factors responsible for the M1 retention happening.
However, our previous result (Qi et al., 2006) clearly showed that
Tra2 has the potential to repress M1 splicing in somatic cells as
long as relatively high level of Tra2 was present. That is
consistent with early observations from our lab that tra2 gene uses
stronger promoter in male germ cells compared with the somatic
promoter to get relatively high level of Tra2 and further achieve
the M1 retention in testis(Mattox et al., 1996).

Hfp was known as a 3’ splice site regulator in mammalian
system to promote weak 3’ splice site recognition (Valcarcel et
al., 2007). However in our RNAi screening, it was identified as a
co-repressor of Tra2 to achieve M1 intron retention. It is
interesting that two splicing regulators who both were known to
promote RNA splicing are also required for the repression of M1
intron splicing. Our previous data has shown that the intronic
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splicing silencer was sufficient for Tra2 to repress intron
splicing in vitro. However in S2 cells, we found only ISS itself
cannot bring the M1 intron retained in the final mRNA but a weak 3’
splice site is also required at the same time, which is consistent
with the observations from our previous in vivo study. When
intrinsic M1 3’ splice site was changed into a consensus one, M1
retention was abolished in testis. When the 3’ splice site was
replaced by another weak one, M1 retention was restored in a
similar level (Chandler et al., 2001). Here we showed that the M1
repression by Hfp and Tra2 depends on both ISS and a weak 3’ splice
site.

There are several studies suggest an exon definition model to
explain the splicing repression by SR proteins. Our previous
results also suggested that the M1 intron retention mediated by
Tra2 could be the result of a transformation from an intron
definition to an exon definition (Shen and Mattox, 2012). From our
in vitro studies, it suggested that Hfp could compete with U2AF50’s
activity in the 3’ region of the M1 intron and form a more stable
complex with Tra2 and other factors on the whole M1, further define
the whole intron with flanking exons as a big exon and cause the
intron retention. It will be interesting to test whether the
complex formed on the M1 intron contain the components of complex E
or complex A?

Hfp is originally identified as a transcriptional factor that
negatively regulate c-myc expression. In our RNAi screen, it is
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possible that the effect we saw by Hfp knockdown is from downregulation of Tra2 level. However our western blot result indicates
that Tra2 level was not affected. And the result of RNA
immunoprecipitation assay further showed that Hfp could
specifically associate with tra2 RNA. These observations lead to
the conclusion that Hfp contributes to the repression of M1
splicing through the function as a splicing factor instead of a
transcriptional factor.

Protein isoforms could have distinct biological functions in
cellular processes (Cartegni et al., 2006; Markovtsov et al.,
2000). Taking Tra2 as an example, its 179aa isoform was shown
unable to repress M1 intron splicing in testis, but the other two
isoforms 264aa and 226aa have the abilities to activate dsx female
specific splicing in somatic cells and repress M1 splicing in male
germline (Mattox et al., 1996). Based on the transcriptome
annotation, the two Hfp protein isoforms are encoded by different
mRNAs that depend on whether extra exon is included in the first
intron. However no report has ever shown the presence of these two
protein isoforms in vivo and any functional differences between
them. In this study we first showed that both of the Hfp isoforms
are expressed in S2 cells and Drosophila, even though S2 cell
contains very low abundance of Hfp58. More interestingly, it is the
full length Hfp68 instead of Hfp58 that can repress M1 splicing in
our S2 cell system, which suggests that the N terminus of Hfp68,
the only difference between the isoforms, is required for Hfp’s
negative regulatory function. Within the N terminus, there are four
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serine and arginine (SR) dipeptides that are not present in
mammalian homologue PUF60 (figure 3-19). It is possible that this
RS containing part is responsible for the protein localization
within the cell, even though it shows no similarity with any
conserved nuclear-localization signal. Although some RS domains of
SR proteins have shown the ability to locate protein into the
nucleus (Caceres et al., 1998), the RS-containing N terminus of
Hfp68 is not comparable with those RS domains with highly repeated
RS dipeptides. So it is not clear how much role of the four RS
dipeptides played on the nuclear localization of Hfp68. It will be
very informative to see whether PUF60 could repress M1 intron
splicing in flies, or Hfp68 with these RS dipeptides mutations
could still help Tra2 achieve M1 intron retention.
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Figure 3-19. The alignment of protein sequences of Hfp68 and Hfp58
The protein sequences of Hfp isoforms were aligned by using
MegAlign software. Only the N terminal parts are shown. The
difference between the isoforms is marked with shaded color. Four

Arginine-Serine dipeptides within the N terminus are indicated with
the arrows.
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Although this unconserved N-terminal domain seems required for
M1 intron retention, the UHM domain located in the C terminus is
not needed for this repression to happen. It suggests the
interaction between U2AFs and U2AF-U2snRNP mediated by UHM domain,
which is important for activating splicing, is not necessary for
the splicing repression of M1 intron. This phenomenon also suggests
that individual domains within Hfp68 are responsible for its
different behaviors during alternative splicing.
The difference of subcellular localization between Hfp58 and
Hfp68 was observed in S2 cells. It helps to explain their
functional difference on M1 intron splicing. Splicing factors can
regulate alternative splicing by adjusting their functional level
accessible to the targets. Some SR proteins are well known in
shuttling between nucleus and cytoplasm to regulate their nuclear
concentration, and further regulate RNA splicing (Caceres et al.,
1998; Cazalla et al., 2002). Hfp58 distributes evenly within the
whole cell compared with Hfp68 highly enriched in nucleus. By this
way, nuclear concentration of Hfp protein was decreased when
endogenous Hfp68 was knocked down and Flag-Hfp58 was overexpressed.
With low concentration of nuclear Hfp protein, its repressive
function on M1 splicing was compromised, which is clearly shown in
our luciferase and qRT-PCR assays. However, we still cannot exclude
the possibility that Hfp58 has the ability to repress M1 intron
splicing since there is still some within the nucleus. Other
experiments need to answer whether this RS containing N terminus
endows splicing activity to half pint protein in vivo. There is
evidence showing the N terminus of PUF60 is sufficient to repress
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c-myc transcription as a transcriptional factor, but our
preliminary data showed the N terminus only of Drosophila Hfp
cannot repress M1 splicing in S2 cells.

Another interesting question is if Hfp58 expresses in vivo and
its localization is across the whole cell, what is its role in the
cytoplasm? So far all of the functions of Hfp are restricted within
nucleus, both transcription and RNA splicing. Instead of decreasing
its level in nucleus to regulate RNA splicing as we speculated
above, is there any possible function on translational regulation
or protein degradation? Even no cytoplasmic function has been
reported for Hfp, in vitro interaction studies identified some
interacting proteins that function in cytoplasm might shed light
for future directions.

The function division among protein isoforms can be seen
extensively in vivo. As a bifunctional regulator with two isoforms,
it will be very interesting to know whether Hfp isoforms have
functional division in vivo that one isoform is responsible for
transcriptional regulation while the other one participate in RNA
splicing. Or both isoforms could be responsible for transcription
and splicing regulation, but two isoforms exhibit different
behaviors for particular substrates. For example as a splicing
factor, one isoform is only for splicing activations and the other
one is just for repressions. There is report showing that Hfp is
differently spliced in male and female flies (Hartmann et al.,
2011). Our preliminary data also suggested that these two isoforms
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are differentially expressed in fly males and females. Considering
M1 intron is only retained in testis while Tra2 level is similar in
both testis and ovary, there could be some sex-specific functions
performed by different Hfp isoforms. Although we found Hfp68 and
Hfp58 have distinct subcellular localization, no data has ever
shown the similar difference present in vivo.

To verify these functional roles in vivo, isoform specific
mutated flies will be extremely helpful. However since one major
function of Hfp resides in germ cells, there is technical
difficulty to delete or overexpress hfp isoforms only in male germ
cells. An improved gal4-UAS tool that could avoid this barrier is
worth a try to test the ideas (Haley et al., 2010; Ni et al.,
2011).

As a cell-based method to study RNA splicing, a potential
drawback of the experiments done in S2 cells is the manner of
transient transfection. With multiple reporters or vectors
cotransfected and also treatment of dsRNAs, considering the
efficiency and cell status of each time experiment, the luciferase
activity could vary a lot from time to time. To avoid this kind of
fluctuation, stable transfected cell lines should be suggested to
establish for the future studies. The stable cell lines could
contain both the M1 reporter and Tra2-PC cDNA.
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CHAPTER FOUR

The Regulation of Alternative Splicing of Taf1 premRNA by Half Pint and Tra2 in Drosophila Testis

Introduction

Alternative splicing, as an essential regulatory step of gene
expression, also plays important roles in germline development.
Numerous alternative splicing events have been reported during male
germ line development as discussed in Chapter One. However the
splicing factors that regulate these events are not known and how
splicing regulator function is integrated into germ cell
development is poorly understood.
The negative autoregulation of M1 splicing by Tra2 is known to
be important for fertility in male flies. Transgenic flies carrying
copies of the Tra2 gene in which autoregulation is impossible due
to a deletion of the M1 intron were found to exhibit dose-dependent
sterility (McGuffin et al., 1998). The sterile males were found to
produce mature sperm, but these do not move into seminal vesicle
indicating that they are immotile. Given that Tra2-PC is
constitutively expressed from this transgene and is the only
isoform of Tra2 that is genetically functional in the germline,
these results suggest that sterility can result from excess Tra2
activity. Thus a limited level of Tra2 in germline is critical for
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male fertility and negative autoregulation plays an important role
in limiting Tra2 expression during spermatogenesis.

Since Half pint was identified in our RNAi screen as a Tra2
co-repressor of M1 splicing and has also been shown to affect
alternative splicing in the female germ line (Van Buskirk and
Schupbach, 2002), it is interesting to know whether Half pint
functions together with Tra2 in a common pathway to regulate other
targets important in spermatogenesis. Both Half pint and Tra2 were
recently implicated in the regulation of alternative splicing of
transcripts from the taf1 gene in response to DNA damage and ATR
signaling in Drosophila cultured cells (Katzenberger et al., 2009).

Taf1 (TBP associated factor 1) is a transcription factor and a
subunit of TFIID. Genetic studies suggest it plays an important
role in cell proliferation and viability in Drosophila. Its premRNA is spliced into mRNAs encoding four distinct protein isoforms.
These mRNAs differ from each other by the inclusions of exon 12a
and exon 13a (figure 4-1). It has been shown that Taf1-2 mRNA is
highly enriched in the fly testis (Katzenberger et al., 2006).
Interestingly, several genes encoding other germline specific
paralogues of TFIID components have been identified in Drosophila
and are known to share similar mutant phenotypes suggesting an
important role in the entry into meiosis and for spermiogenesis
(Hiller et al., 2004). These factors differ from Taf1-2 in that
their tissue specific expression is determined transcriptionally
rather than by alternative splicing. Taf1 null mutants are lethal,
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but hypomorphic alleles are sterile in both female and male flies
(Wassarman et al., 2000). It is reported that Taf1 proteins
expressed in the testis co-localize with other TFIID components and
is thought that Taf1 may be required for the integrity of testis
TFIID complex (Metcalf and Wassarman, 2007).

In this Chapter I will explore the relationship of Half pint
and Tra2 in promoting germline development and test how they impact
germline specific alternative splicing of Taf1 in vivo.
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Figure 4-1. The diagram of taf1 mRNA isoforms
The exon-intron pattern of Taf1 pre-mRNA is shown. Gray boxes
correspond to exons and horizontal lines to introns. Red boxes
represent exon 12a and blue boxes represent exon 13a. Taf1 mRNA
isoforms with different exon inclusion patterns are shown with the
names labeled to the right side of the diagram.
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Materials and Methods
Fly stocks
Stocks used bearing tra2 mutations had the following genotypes:
w1118/BsY; tra-2B/CyO, w1118/BsY; tra-2PM6/CyO, w1118/BsY; tra-2PM7/CyO,
w1118/BsY; B1 tra-2/CyO. w1118/BsY; Df(2R)Trix/CyO.
Hfp mutants used were from the following strain genotypes and were
obtained from Trudi Shupbach:

w;hfp13/TM6B,Hu. w;hfp9/TM6B,Hu.

Df(3L)Ar14-8,red[1]/TM2,p(p). hfp3058,recl/TM3,Ser.
Taf1 mutants were obtained from the Bloomington Drosophila stock
center: w1118;taf1EP421/TM3,Sb. w1118;taf11 red1 e1/TM3,Sb. y1; taf1R14
red1 e1/TM2.
RNAi and GAL4 strains were of the following genotypes and were
obtained from Drosophila Stock Center: y sev;VAL20-Puf68(y+v+). y
sev;VAL20-Taf1(y+v+). P[Gal4::VP16-nos.UTR]MVD1.
The strain w,P[m-w+,bam-Gal4-VP16] was obtained from Dennis
McKearin (Chen and McKearin, 2003).

Primers for PCR
Primers used in RT-PCR for Exon12a splicing were:
Exon 12 forward: 5’-GCATGCCTCCTCATCGAACTC
Exon 13 reverse: 5’-CATGCCATCCATGGCATCGG
Primers used in RT-PCR for Exon 13a splicing were:
Exon 13 forward: 5’-CCGATGCCATGGATGGCATGT
Exon 14 reverse: 5’-AGGCCCATTATCATCCTGCT
Primers used in qRT-PCR for Exon 12a splicing were:
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Exon12a inclusion product: E1212a forward: 5’CGTGGAGGAGGTCAAATCCC
E12a13 reverse: 5’-TCGTCGTCGTCCTCGTCATC
Exon12a skipping product: E1213 forward: 5’CGTGGAGGAGGATCTCCAAT
E13 reverse: 5’-CGCCCTGATCTAAAATGCTC

Primers used in qRT-PCR for marker gene expression were:
Twine: forward 5’-ACAATTGGGAAGCCAGGGCGG,
reverse 5’-TCGTTGCTCCGCAGGTAGCG
fzo: forward 5’-TTGGGCTTCCGATCGCCGAG,
reverse 5’-AAAGGTGGCAGGGGCGAACA
aly: forward 5’-GGTCAGCAGTTTTCTGCACG
reverse 5’-AATCCGGAAGACTGAGCACG
can: forward 5’-GGAAATGTCATTGCGTCCCG
reverse 5’-GGGTCCTAATGGCTTCGTCG
bol: forward 5’-GTGAGCAAGGGCTACGGATT
reverse 5’-CTTTTTGATGGCCGGTGCAA
cycA: forward 5’-TTTTGAGCCAAATGGCGGTG
reverse 5’-TGGTGTAACTGTCGTCGGTG
cycB: forward 5’-GGCAGATCCGACAGATGGAG
reverse 5’-TGGACATCGTATGGTGCTCG
RpL32: forward 5’-AGCATACAGGCCCAAGATCG
reverse 5’-CTTCTTGAATCCGGTGGGCA
RT-PCR for genomic verification:
Hfp mutant: forward 5’-TCCCCACAGTTACTCAAAACCTATC
reverse 5’-GTTTGGTGCGAGTTAAAAAGTGTCT
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Taf1ep421: forward 5’-CGGACATGCTAAGGGTTAATC
reverse 5’-CAGCATAGAATCCAGACCCA
Bam-gal4: forward 5’-AGGTGACCATAAATTGAAAC
reverse 5’-GTTCCAGTCTTTCTAGCCTT

Real-time PCR
cDNA was synthesized in 20µL of total volume with 1µg total RNA by
Superscript first strand RNA kit. 2µL of cDNA from this reaction
was used as template for PCR amplification. It was mixed with 2X
Syber Green PCR mix from ABI and supplemented with primers at a
concentration of 0.625 ng/µL. PCR was performed using the following
cycle conditions: 50oC 2minutes and 95oC 10 minutes, followed by
95oC 15 seconds and 60oC 1 minute for 40 cycles.

Fertility test
Single male flies were cultured with three w1118 virgin females.
Vials were cleared after flies were kept together for one week and
offspring were counted at the pupal stage.

Live cyst dissection
Testis were dissected in the testis dissection buffer (TDB, 0.183M
KCl, 47mM NaCl, 10mM Tris-Hcl, pH 6.8). Single testes were loaded
on a slide with 30 µL TDB. The anterior third of the testis was
peeled open and placed under a coverslip. Extra TDB was soaked
gradually with Kimwipe under a phase contrast microscope (Leica DMR)
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and observed until intact cysts were pushed out of the organ.
Cells within intact cysts were counted. Pictures were taken with a
Photometrics Quantix camera.

Testis immunostaining
Testis from wild type flies and other mutant flies were dissected
in TDB and mounted onto slide in a 30µL (intact testes) or 20µl
(squashed testes) volume of TDB and covered with a 20mm coverslip.
Slides were frozen in liquid nitrogen for more than 30 minutes. The
coverslip was then removed with a razor blade and immediately put
into fixation buffer (4% formaldehyde, 8% acetic acid, 15% ethanol
in 1XPBS). After incubating at room temperature for 10-15 minutes,
slides were placed in 50% acetic acid buffer to wash for one minute,
followed by three washes in PBS and then incubated for 30 minutes
in 0.5% PBX (0.5% Triton X-100 in PBS). This was followed by
blocking with 1% BSA in PBS for 30 minutes at room temperature
followed and incubation with anti beta-tubulin antibody (1:200 in
1% BSA) (Developmental Studies Hybridoma Bank) at 4oC over night.
The next day, slides were incubated with fluorescent secondary
antibodies (diluted 1:500 in PBX) at room temperature for 2-2.5
hours after washing three times with PBX. Finally, they were
stained with PI (1:5000) for 5 minutes at room temperature and
washed three times. Images were taken with Nikon Eclipse Ti
confocal microscope.
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Single fly PCR
One fly was squashed with 200µL tip containing 50µL SB buffer (10mM
Tris 8.0, 25mM NaCl, 1mM EDTA and 200ug proteinase K) in 1.5mL
eppendorf tube. After macerating 20 times, residual SB buffer was
expelled and the homogenate was incubated at 37oC for 30 minutes and
then 95oC for 2 minutes. Samples were spun 7500 rpm for 10 minutes
in an eppendorf microfuge. Finally 2µL of the supernatant was used
as template for PCR reactions.
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Results
1. Half pint and Tra2 have opposite effects on the
alternative splicing of Taf1 exon 12a
Alternative splicing of Taf1 pre-mRNA produces four isoforms
with different inclusion strategies of two alternative spliced
exons: exon 12a and exon 13a. Previous studies conducted in S2
cells reported that in response to ATR signaling, Tra2 and Hfp were
required for the upregulation of mRNAs encoding two Taf1 isoforms:
Taf1-3, which includes exon 13a, and Taf1-4 which includes both
exon 12a and exon 13a (Katzenberger et al., 2009). In vivo, the
same authors found that Taf1 isoforms have distinct expression
patterns in different tissues. Taf1-2 is highly enriched in the
testis (Katzenberger et al., 2006). Exon 12a is the only
alternatively spliced exon included in this mRNA. So I tested
whether the splicing of this exon is changed in the testes of flies
with loss of function mutations in tra2 and hfp. Testis RNA from
several different heteroallelic mutant genotypes was isolated and
used to do both conventional RT-PCR and as well as real time Q-PCR.
As shown in figure 4-2, the RT-PCR result showed that more exon 12a
was included in RNA from tra2b/tra21 loss-of-function mutant testes,
while it's skipping was increased over wild type controls in Hfp
mutant testis. Confirming this observation, similar results were
seen in Q-PCR experiments. Again, more exon 12a inclusion was
observed in each of three different Tra2 mutant genotypes and less
exon 12a inclusion was found in both hfp mutant genotypes tested.
Exon inclusion was increased around 1.5 fold in tra2 mutants but
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decreased by more than 2 fold in Hfp mutants. These results
indicate that the Tra2 protein normally functions to inhibit
inclusion of this exon while Hfp acts to favor inclusion. Thus,
unlike the M1 intron where Tra2 and Hfp collaborate to repress
splicing, the effect of Hfp on exon 12a splicing is opposite to
that of Tra2.
Alternative splicing of exon 13a was also tested, but no
dramatic effect on its inclusion was seen in RNA from either tra2
or Hfp mutant testes (figure 4-2). It should be noted that these
effects of Hfp and Tra2 on splicing in the germline are distinct
from those observed earlier in studies on Drosophila S2 cells
subject to genotoxic stress (Katzenberger et al., 2009). Thus these
factors have different effects on splicing during normal germline
development.
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Figure 4-2. Hfp and Tra2 have opposite effect on exon 12a splicing
in Drosophila testis
(A) RNA from testis of Drosophila with various genotypes was used
for RT-PCR. Primers positions are indicated in the diagram. More
exon 12a inclusion was observed in the testis of tra2 mutant flies,
while the same exon was reduced in Hfp mutants. (B) Additional
genotypes were analyzed by quantitative RT-PCR. The ratio of
transcripts with and without exon 12a in the control strain w1118 was
set at 1.0 and results from other strains and used to normalize
results in this comparison. In three different tra2 mutants, the
transcripts with exon 12a inclusion were consistently increased,
while a 2-fold decrease was observed in Hfp mutants. The Df(2R)Trix
chromosome is indicated as Df(tra2). The Df(3L)Ar14-8 chromosome is
indicated as Df(hfp).
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2. Overexpression of Tra2 in vivo does not cause more exon
12a exclusion
As M1 splicing of Tra2 transcripts in the germline is
increased in Hfp mutants (figure 4-3A) these mutants are expected
to have higher levels of Tra2 activity in the form of increased
Tra2-PC. Therefore the opposite effects of Hfp and Tra2 on Taf1
splicing might be explained in either of two ways illustrated in
figure 4-3B. One possibility is that Hfp and Tra2 function in
parallel paths to independently regulate exon 12a splicing (figure
4-3B1). Another possibility is that the effect of Hfp on exon 12a
is actually a secondary consequence of its effect on M1 repression
and Tra2 activity (figure 4-3B2). Without Hfp dependent negative
feedback, excess Tra2 is expected and this could lead to the
effects opposite to those of loss-of-function Tra2 mutants. To
distinguish these two possibilities, exon 12a inclusion was tested
after increasing the expression of Tra2-PC in vivo.
We used two approaches to increase Tra2 level in male flies.
In the first method we attempted to overexpress Tra2 specifically
in primary spermatocytes using Gal4-UAS system. Tra2 expression was
driven from a UAS-mycTra2 transgene produced previously in our
laboratory and used to study overexpression of Tra2 in the soma (Qi
et al., 2006). GAL4 expression was obtained using the Bam-GAL4
transgene known to be active specifically in pre-meiotic
spermatogonia and spermatocytes. However, based on RT-PCR
experiments, we observed that this system produced only a very
small effect on overall Tra2 mRNA levels in the testis (figure 4-
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4B). As shown in figure 4-4A, no effects on taf1 exon 12a inclusion
were seen in qRT-PCR experiments with Gal4-driven expression of
either Tra2 or Hfp.
Because the above results were inconclusive we further
explored this splicing regulation working model using several fly
strains that contain two copies of a tra2 transgene with the M1
intron has been deleted. As discussed in the Introduction, Tra2
keeps its expression level constant in testis by negatively
autoregulating M1 intron splicing (figure 4-5A). This M1 intron
deleted transgene is expected to escape negative regulation by Hfp
and thus, if Hfp affects Taf1 splicing through its effects on M1,
the presence of the transgene should rescue such effects (figure 45B,C). Exon 12a inclusion was tested by Q-PCR (figure 4-6). However
no difference was observed between the transgenic flies with
constitutive Tra2 expression and controls. In this case RT-PCR
experiments confirmed that the tra2 mRNA amount were increased
within Tra2 overexpression testis. The increased level was
comparable to that in Hfp mutant testis (see figure 3-12). This
result suggests that the effect of exon 12a splicing we saw in Hfp
mutant is not due to the epistasis regulation of tra2 splicing. Hfp
functions in parallel with Tra2 on the exon 12a.
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Figure 4-3. Models of RNA splicing regulated by Hfp and Tra2 in the
male germline
(A) Hfp and Tra2 are both required to repress M1 intron splicing
from tra2 pre-mRNA. Hfp and Tra2 function oppositely in the
inclusion of exon 12a splicing in Taf1 mRNA. (B) Two possibilities
for the regulation of exon 12a mediated by both Hfp and Tra2. 1)
Hfp indirectly affects exon inclusion by negatively regulating Tra2
splicing, and expression of functional Tra2 protein. 2) Hfp and
Tra2 function in parallel to control inclusion of the exon.	
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Figure 4-4. The Bam-GAL4 drivert failed to increase expression of
mRNAs from UAS-mycTra2 or UAS-Hfp and had no effect on exon 12a
splicing (A) Testis RNA from both the wild type control w1118 and
other control and experimental genotypes was examined quantitative
RT-PCR. GAL4-UAS driven expression of Tra2 and Hfp had no effect on
exon 12a splicing, compared with Bam-Gal4 control. Error bars
represent the standard deviations of the means. (B) Further RT-PCR
analysis of RNA from these genotypes indicated that neither Hfp nor
Tra2 mRNA levels were significantly increased by the GAL4 and UAS
transgenes.
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Figure 4-5. Mutated tra2 gene escapes its negative auto-regulation
(A) The diagram showing two mRNA isoforms that are produced by the
alternative splicing of tra2 RNA in the male germline. One of the
isoforms encodes a functional Tra2 protein with 226 amino acids
(also called Tra2-PC). (B) The diagram illustrating how an
artificial transgene without the M1 intron can escape negative
regulation and keep the Tra2-226 level constantly high in vivo.
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Figure 4-6. Increasing Tra2 in testis does not affect exon 12a
splicing
Testis RNA from both w1118 and various genotypes was used to do
quantitative RT-PCR (graph above) and regular RT-PCR (gel image
below) in parallel. Both 34-2/34-2 (tra2+ background) and 41.7/6-1
(insertion in the second chromosome that is balanced with CyO
balancer) are transgenic strains carrying two tra2 transgenes
lacking the M1 intron. Although Tra2 mRNA levels were increased, no
effect on exon 12a was observed in these two genotypes as compared
with wild type (w1118) and tra2b/Cyo controls. Note that the P value
of 41.7/6-1 in relation to tra2b/Cyo control is 0.736. Tra2 mRNA
levels are shown to be increased in the RT-PCR analysis below the
graph. Error bars represent the standard deviations of the means.
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3. Hfp and Taf1 are both required for male fertility and the
formation of motile sperm
Given its role in Taf1 splicing we next examined whether Hfp
is required for normal spermatogenesis. As shown in figure 4-7, two
of the Hfp mutant genotypes tested displayed significant male
sterility. In addition, among males that displayed fertility there
was a dramatic decrease in the number of offspring produced. To
determine if sterility was due to an absence of mature sperm we
examined the seminal vesicles of sterile Hfp mutants and compared
them to wild type. The empty seminal vesicles of the mutants
indicate a failure to produce mature motile sperm. We conclude that,
like Tra2, Hfp plays an important role in spermatogenesis.
Because Taf1-2 is highly enriched in the male germline and is
alternatively spliced under the control of both Hfp and Tra2, we
next examined whether Taf1 expression is similarly required for
male fertility. To address this issue we first examined available
mutations in Taf1. Strong loss-of-function mutations in Taf1 are
lethal, and at least one available viable hypomorphic genotype
tested produced only fertile males (table 4-1). We therefore turned
to RNA interference to produce a tissue specific knockdown of Taf1
function. We took advantage of the Gal4-UAS system to drive Taf1
dsRNA expression specifically in male germ cells. Transgenic flies
bearing a construct that produces Taf1 dsRNA from the VAL20 vector
were used in these experiments (Haley et al., 2010). This vector is
driven by the GAL4 system but is reported to be effective in the
male germline and therefore we expected to avoid the low-expression
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issues encountered in earlier with germline specific expression
experiments. The Gal4 transcriptional activity is driven by Bam
promoter which starts transcription in transit amplifying
spermatogonia (Chen and McKearin, 2003) which corresponds with the
earliest stages where Taf1 is detected (Metcalf and Wassarman,
2007). Using this approach we observed that taf1-RNAi males are
completely sterile (figure 4-7).
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Figure 4-7. Fertility test of both Hfp and Taf1 mutant males
(A) Offspring from males with various genotypes crossed with wild
type virgins were counted and summarized in the graph. The males
producing any offspring are defined as fertile. Numbers above the
column represent fertile males versus total tested males. Males
from both Hfp mutants showed dramatically decreased fertility and
complete sterility was observed in taf1 RNAi mutant males. Error
bars represent the standard deviations of the means. (B) Expression
level in taf1 mRNA in RNAi flies. RT-PCR assays were done with
testis RNA from various genotypes. Flies carrying both Bam-Gal4 and
the taf1 dsRNA constructs are expected to express taf1 dsRNA in the
male germline. Flies carrying Bam-Gal4 and taf1EP421 are expected to
have increased Taf1 pre-mRNA synthesis as the UAS elements are
located immediately upstream of the endogenous Taf1 gene, as
illustrated in (C).

	
  

	
  

158	
  

Males !

No. fertile/No.
tested!

No. of progeny
per fertile male!

w1118!

10/10!

79.4 ± 15.1!

taf1R14/taf1EP421!

9/10!

81 ± 10.45!

taf11/taf1EP421!

lethal!
	
  

	
  
Table 4-1. Fertility tests of Taf1 mutants
No effect on the fertility of taf1R14/taf1EP421 mutant was observed.
The other mutant taf11/taf1EP421 is lethal.
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4. Half pint is required for a normal number of transit
amplifying mitotic divisions in spermatogonia
Spermatogenesis in Drosophila starts with production of gonial
cells from germline stem cells located at the anterior tip of the
testis. These gonial cells will divide four times in synchrony with
incomplete cytokinesis to form a cyst of 16 interconnected cells.
The cyst is surrounded by two somatic cyst cells. These divisions
are referred to as transit amplifying mitotic divisions because
they amplify the number of products from the stem cell. Once the
spermatogonia number reaches 16, they will stop dividing and start
to grow. By the time spermatocytes enter meiosis they have
increased in volume by 25 times (Insco et al., 2009). The whole
process is illustrated in figure 4-8.
Examination of early spermatogenesis revealed that in each of
several half pint mutant genotypes (hfp13/hfp9 see figure 4-9,
hfp13/hfp3058, hfp13/Df(3L)Ar14-8 data not shown) the majority of
spermatocyte cysts produced 8 rather than the usual 16 germ cells.
This suggests that, like in the female germline, Hfp is required to
promote a fourth mitotic cell division. Examination of the
morphology in these cysts indicates that the cells within them have
features distinctive of spermatocytes (large and round nuclei and
prominent nucleoli, no sign of dividing). Moreover in a manner
similar to 16 cell cysts, they grow dramatically after mitosis is
completed and are able to enter meiosis upon completion of the
growth phase (see below). These results indicate that Hfp is
required to determine the number of spermatocytes/cyst but are not
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required for other visible pre-meiotic events. We also examined
spermatocytes from tra2 mutants, but consistent with previous
reports, the loss of function for this gene had no visible effect
the number of mitotic divisions or on spermatogenesis prior to
meiosis (figure 4-10).
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Figure 4-8. Illustration of spermatogenesis in Drosophila
Germ cells within the adult testis are illustrated on the left. The
yellow circle at the tip represents the germline stem cell. Gray
circles around it represent cyst cell progenitor. Red circles
represent spermatocytes in the stages of both mitosis and postmitotic growth. Blue circles correspond to spermatocytes in
meiosis. Black circles and lines represent spermatids in postmeiotic differentiation stages.
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Figure 4-9. Eight-cell spermatocyte cysts were produced in the
testis of Hfp mutants
Testes from Drosophila adults of various genotypes were dissected
and gently opened under pressure of a coverslip. Spermatocyte cysts
were counted under phase contrast microscope. The percentage of
cysts with various number of spermatocytes in each mutant testis
are shown in graphs. In hfp13/hfp9 mutant testis more than half of
the cysts contained 8 spermatocytes, while all the cysts in taf1
RNAi testis contained 16 spermatocytes. The number of cysts counted
(N) is indicated in each graph. Typical cyst phase contrast images
are shown on the right side of the graphs.
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Figure 4-10. The testis of Tra2 mutant flies contain cysts with
normal numbers of spermatocyte
Testes from two tra2 mutant genotypes were dissected and peeled
open. Spermatocyte cysts were counted under phase contrast
microscope. Percent of cysts with different number of spermatocytes
in each mutant testis are shown in graphs. The number of
spermatocytes in each cyst is normally 16, and no cyst with
abnormal numbers of spermatocytes was observed. Total cysts counted
for each genotype (N) are indicated. Phase contrast images of
typical cysts are on the right side of the graphs. The Df(2R)Trix
chromosome is indicated as Df(tra2). 	
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5. Half Pint is required for normal spermatogenesis
To further investigate how spermatogenesis is altered in Hfp
mutants we examined the morphology of mature spermatids using,
propidium iodide to stain DNA and antibodies against beta-tubulin,
which is a major structural component of the spermatid tails. In
wild type testes, as shown in figure 4-11, each cyst matures to
form a bundle of aligned elongated spermatids with condensed nuclei.
These accumulate primarily near the posterior end of testis
(indicated with the arrow) where individualized mature sperm will
eventually swim into the seminal vesicle. Prior to the completion
of maturation, spermatid are nicely aligned with highly condensed
needle like nuclei, identified with PI staining, and long tails
identified by beta-tubulin staining (figure 4-11). However in Hfp
mutants, clusters of aligned nuclei were not observed. Instead, the
number of condensed nuclei is significantly diminished (figure 411). Of the scattered nuclei observed, very few were elongated to
form the needle-like shape formed in wild type. In addition the
regular spatial relationship between nuclei and the tails found
within normal cysts was lost. Based on beta-tubulin staining, tails
appeared to be irregularly formed and nuclei were distributed
within tails randomly (figure 4-11).
To visualize individual cysts we tried squashing testes
stained by anti beta-tubulin antibody and propidium iodide. As
shown in figure 4-12, wild type testis showed nice alignment
between spermatids that included both the nuclei and tails. But
condensed nuclear bundles were not observed in Hfp mutant. Instead,
large and irregularly shaped nuclei were scattered and no clear
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connection was observed with tails. These observations suggest that
during spermatid differentiation, the coordination development of
spermatid heads and tails is impaired.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
	
  

	
  

166	
  

	
  

	
  
Nucleus!

Beta tubulin!

Nucleus!

Merge !

w1118!

hfp9/hfp13!

Bam-Gal4!
taf1 dsRNA!

	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  

167	
  

Figure 4-11. The differentiation of spermatid is impaired in both
Hfp and Taf1 mutant testis
Whole testis were dissected and stained with anti-beta tubulin
antibody (green) and PI (red). Less sperm head bundles and tails
were observed in both Hfp and Taf1 mutants. The magnified field
from each image is indicated by the white square frame on the left.
Few or no clusters of spermatid nuclei and fewer tails were seen in
both Hfp and Taf1 mutants. Further, sperm nuclei were not found at
the end of the cluster but rather were distributed throughout the
cyst. The sperm nuclei showed irregular shaped instead of needle
shaped in wild type.
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Figure 4-12. Hfp and Taf1 mutant males contain less sperm bundles
and tails
Immunostaining like in the previous figure is shown on spermatid
cysts from squashed testes. Fewer recognizable nuclear bundles and
tails were observed in both Hfp and Taf1 mutants. The magnified
field from each image was indicated with white square frame on the
left. Similar phenotypes with that in figure 4-11 were observed.
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6. Hfp is required for correct meiosis during spermatogenesis
The failure to produce normal mature spermatids could be due
to aberrations in spermatid differentiation or to defects that
occur in meiosis. To examine how these processes are affected by
Hfp, we characterized cellular phenotypes of cysts at earlier
stages.
Examination of the testis as a whole showed that, in relation
to wild type, Hfp mutant testis was in a relatively smaller size,
which could be due to the observation that more than half of the
cysts contained 8 spermatocytes instead of 16. Also Hfp mutants
contained less sperm tails as indicated in wild type, which is
consistent with the results of immunostaining assay, and suggests a
relatively low number of mature spermatids (figure 4-13).
After meiosis is completed, 64 spermatogonia are normally
found in each cyst. The mitochondria in the cytoplasm of each cell
aggregate and fuse with each other to form a structure called a
Nebenkern, which is a dark spherical structure under phase contrast.
In normal testes, a single Nebenkern is found closely associated
with the cell nucleus and is about the same size, as shown in the
w1118 cyst in figure 4-14. Changes in this arrangement are observed
in Hfp mutants and are indicative of mistakes in meiosis. For
example, we observed that Hfp mutant spermatids associated with
multiple Nebenkern suggesting a failure in cytokinesis (figure 414). In addition we found that nuclei of varying sizes were often
found in postmeiotic cysts of Hfp mutants and that their size often
differed substantially from that of the Nebenkern and from that of
nuclei found in normal cysts at a similar stage. This variance in
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size is an indication of chromosomal aneuploidy and suggests that
the mutant cells fail to undergo normal chromosome segregation.
Thus it is likely that Hfp mutants suffer from multiple defects in
the process of meiosis in the male germline.
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Figure 4-13. Decreased amount of sperm tails developed within Hfp
and Taf1 mutant testis
Testes from one-day old male were dissected and images were taken
with phase contrast microscope. Whole testis images were rebuilt
with the same magnification scale. Genotypes are labeled on the
left of the images. More white fibers are seen in wild type testis
as indicated by the arrows.
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Figure 4-14. Evidence of meiotic defects in Hfp and Taf1 mutant
testes
(A) Abnormal cytological phenotypes were observed in the onion
stages of spermatid differentiation. Testes were dissected and
squashed in the dissection buffer. Images were taken with phase
contrast microscope. Nucleus are indicated with red arrows, and
Nebenkern are indicated with blue arrows. Variably sized nuclei
(white circles) were seen in both Hfp and Taf1 mutants, as
indicated with red arrows. Multiple nucleus associated with one
cytoplasm were also seen in both Hfp and Taf1 mutants as indicated
with blue arrows. (B) In slightly later stages of spermatid
differentiation Nebenkerns begin elongation as shown in the wild
type control (w1118), but this abnormal in cysts from either Hfp or
Taf1 mutants. In these cells Nebenkerns had irregular shapes and
were associated with multiple small nuclei.
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7. Comparative analysis of spermatogenesis phenotypes in Hfp, Tra2
and Taf1 mutants
Analysis of splicing in Hfp and Tra2 mutants indicates that
these factors have opposite effects on the regulation of taf1 exon
12a splicing. Specifically, Hfp was observed to be required for
normal levels of the exons inclusion which in turn leads to the
expression of the testis-specific Taf1-2 protein isoform. If Taf1-2
plays an important role in germ line development, we might expect
that Taf1 loss-of-function genotypes would display phenotypes that
overlap those of Hfp mutants. Interestingly it is reported that 8
cell egg chambers, like those observed in Hfp females have been
observed in the oogenesis of Taf1 mutants (Wassarman et al., 2000).
But how the male germ cell development is affected by loss of Taf1
has not been reported.
To address this issue taf1-RNAi whole testis were examined by
phase contrast, as seen in figure 4-13, Taf1 loss-of-function
gonads was primarily filled with spermytocytes and relatively few
mature spermatids are seen. This is consistent with the result from
whole testis staining with anti beta-tubulin antibody. As shown in
figure 4-11 and 4-12, few sperm tails were formed and almost no
spermatid head bundles were seen in the whole testis of taf1-RNAi
mutant. The phenotype is similar when squashed testis was stained.
Spermatid tails are short, poor aligned with each other. Nuclei are
relatively large and irregularly shaped in contrast to the needleshaped nuclei seen in wild type. Like in Hfp mutant spermatids were
not well aligned and nuclei were observed to be distributed
throughout the tails.
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Under phase contrast, cytogenetic defects can be seen in the
stages after meiosis (figure 4-14). Relatively large nuclei were
seen in the stage of condensation. At the same time, uneven
divisions produced many daughter nuclei with bigger and smaller
sizes clustered within the same cyst. Some daughter nucleus shared
the same Nebenkern, while some cells lost nucleus but has only
Nebenkern left. However no 8-spermatocyte cysts was seen in taf1RNAi testes (figure 4-9).
These observations together suggest that Hfp and Taf1 mutants
share some common phenotypes during spermatogenesis. And the
phenotypes in taf1-RNAi mutant are more severe.
Unlike Hfp and Taf1, in both of two well studied Tra2
genotypes tested, tra2B/tra21 and tra2B/Df(2R)Trix, only 16spermatocyte cyst was seen as shown in figure 4-10. Interestingly,
this mutant also affects sperm nuclear morphology as described
previously (Belote and Baker, 1983), but no effects on meiosis were
observed in these testes.

8. Meiosis-related markers are affected similarly in Hfp and
Taf1 mutants
Since similar meiosis defects were observed in both Hfp and
Taf1 mutant testis, we tested whether the molecular markers
involved in meiosis were similarly affected by these two factors.
The markers tested included the meiosis related genes always early
(aly), cannonball (can), twine, cyclin A and cyclin B as well as
the spermiogenesis-related genes don juan (dj) and fuzzy onions
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(fzo). These particular markers were selected based on their
previous characterization in studies on another meiosis-related
gene mutant in the germline (Ayyar, 2003). Gene expression levels
were examined by qRT-PCR in RNAs from taf1 RNAi and Hfp mutant
testis. Mutations in the always early (aly) and cannonball (can)
genes both produce meiosis-arrested phenotypes and these factors
are thought to regulate transcription of target genes involved in
entering meiosis. Expressions of cyclin A, cyclin B and twine are
indicative of various steps related to meiosis initiation. Don Juan
(dj) and fuzzy onions (fzo) are both genes required for the
differentiation of functional sperm. As shown in figure 4-15,
cyclin A and cyclin B were both significantly increased in Taf1
mutant, similar but rather milder effects were seen in Hfp mutant.
Twine has no statistically significant increase in both Hfp and
Taf1 mutants, but its trend of changes are similar in the two
mutants. Since cyclin A and twine RNA are both accumulated in late
G2/M spermytocytes, the increase observed in their level is
consistent with microscopic observations that these mutant testes
have an increased proportion of pre-meiotic spermytocytes (figure
4-13). Transcripts from dj were dramatically decreased in both Taf1
and Hfp mutant. Since it was reported that dj is involved in the
spermatid differentiation and maturation (Santel et al., 1998), its
decreased level in both mutants is consistent with the staining
result that sperm in both mutants showed developmental defects.
However can was only down regulated in Hfp mutant. Cannonball is
another testis-specific taf gene that is known to regulate
downstream targets involved in meiosis (White-Cooper et al., 1998).
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Its decreased level only observed in Hfp mutant suggests that Hfp
might be in a higher position of the hierarchy of gene expression
during spermatogenesis, but Taf1 is a downstream target. Other
markers tested were not significantly affected in either mutant.
This observation differs from that reported for mutations affecting
genes encoding other germline specific Taf proteins which have more
global effects on factors involved in meiosis and spermiogenesis
(Ayyar, 2003; Hiller et al., 2004).
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Figure 4-15. Expression levels of genes that are involved in
meiosis in both Hfp and Taf1 mutant testis
Gene expression levels of various marker genes are indicated as
determined by qRT-PCR performed on RNA from dissected testes. All
samples were normalized to parallel amplifications of the ribosomal
protein L32 mRNA. Error bars represent the standard deviations of
the means.
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9. Examination of the fertility of Hfp mutant males affected
by forced expression of Taf1
If the phenotypic effects of Hfp on meiosis and spermiogenesis
are due to it's effects on the expression of Taf1-2, then the
forced expression of this product is expected to suppress (rescue)
the sterility phenotypes of Hfp mutants. The taf1EP421 allele
contains an EP element inserted in the first exon of Taf1. The EP
element is a P element derived construct that contains UAS target
sequences of Gal4 transcriptional factor at its 3' end. In the
presence of GAL4, the gene downstream of the EP element will be
transcribed in a tissue specific manner. To test whether a forced
increase in Taf1 in spermatocytes results in rescue of the Hfp
mutant phenotype we combined this EP element with the Bam-GAL4
driver transgene in a Hfp mutant background. To build such a strain,
a genetic recombination strategy was used to combine four elements
within one genome: two Hfp mutant alleles, the Bam-Gal4 transgene
and taf1EP421. The genetic scheme we used is shown in figure 4-16 and
the increased taf1 expression level in the males produced was
confirmed in results that are shown in figure 4-7.
The fertility of four element male flies were tested in
crosses with wild type virgins. After mating, the genotypes of all
male parents were verified by PCR (figure 4-17). Fertility test
results are summarized in figure 4-18. The mean numbers of progeny
in these crosses were 21.2 and 16.7 compared with Bam-Gal4;
hfp9/hfp13. This suggests that increasing overall Taf1 transcription
in this way had little, if any, effect on the fertility of Hfp
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males. However we did note differences in the frequencies of males
producing larger numbers of progeny. All wild type males tested
produced more than 60 offspring, but individuals with this level of
fecundity were not observed among Hfp mutants that carried Bam-Gal4.
In contrast 8-15% of Hfp mutant males with Taf1 overexpression
produced more than 60 offspring. This suggests that although the
fertility of most mutant males is unaffected by increased Taf1
expression, a small fraction of individuals has significantly
increased fecundity. These observations warrant further
investigation in the future as they may indicate an important role
for the regulatory relationship between Hfp and Taf1 splicing.
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Figure 4-16. The schemes for fly crosses to generate strains with
Taf1 overexpression in a Hfp mutant background
The genetic scheme for producing the fly strain with both hfp13 and
taf1EP421 is shown in part A. The production of the other fly strains
with both hfp9 and Bam-Gal4 is shown in part B. The processes of
producing other controls are shown in part C-E.
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Figure 4-17. The verification of genotypes of recombined male flies
Genotypes were tested with the primers specific to hfp, Bam-Gal4
and EP421 by PCR. Genomic DNA was isolated from single male flies.
Genotypes are indicated above the images. PCR products are labeled
by the sizes and names. Both Hfp alleles contain a partially
excised P element in the 5’ UTR. The insertion left behind the
excision was about 80 nt in hfp13 mutant, and 480 nt in hfp9 mutant.
The upstream primer used for amplifying hfp alleles is located
upstream of the P element insertion site and the downstream one is
within the hfp intron 1 (A). The PCR product of the wild type
allele is less than 300 nt. No wild type allele was detected in the
hfp9/hfp13 mutant genome (A,B). Primers internal to the Bam-Gal4
element are used to detect it, as shown in (A) no signal of BamGal4 was detected in the wild type. Primers used for the EP421
element are located at the boundary of the insertion site. The
element was not detected in wild type genome as shown in (A). Lanes
labeled “Gal” represent the Bam-Gal4 element, “EP” represent the
EP421 element.
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Figure 4-18. Fertility rescue test of Hfp mutant males by
overexpressing Taf1 in testis
Individual males flies from different genotypes were crossed with
wild type virgins. Percent of tested males with different numbers
of offspring are summarized in the graphs. Genotypes are shown
above the graphs. The numbers of tested males are indicated (N).
The mean number of progeny (M) are indicated. P values of each
group are compared with the control genotype Bam-Gal4; hfp9/hfp13.
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Discussion

Although Hfp and Tra2 are both identified in the regulation of
Taf1 exon 12a splicing, and some similar phenotypes are observed in
mutants, one fundamental question is whether this alternative
splicing event has any biological significance or is important for
the normal spermatogenesis. As a transcriptional regulator, Taf1-2
is highly enriched in Drosophila testis. Taf1 protein has two AT
hook motifs, one is encoded in exon 12 and the other one is encoded
in exon 12a. So only Taf1-2 and Taf1-4 contain both AT hook motifs
in their final protein products. Previous studies have shown that
both AT-hook motifs are required for Taf1 to bind to DNA target
efficiently. Thus alternative splicing of exon 12a is predicted to
directly affect the transcriptional activity of Taf1’s downstream
targets, such as beta-tubulin, string and Don juan (Metcalf and
Wassarman, 2006). By regulating exon 12a splicing, Hfp and Tra2 are
potentially able to affect the binding activity and further the
transcription function of Taf1. Therefore the regulation of exon
12a inclusion influences the process of male germ cell development.
The phenotypic similarities between Hfp and Taf1 mutants shown in
our experiments suggest this prediction and the importance of Taf12 alternative splicing during spermatogenesis. Additional
experiment with Taf1-2 specifically expressed in the testis of Hfp
mutant background would verify this idea. Partial rescue of the
phenotypes in Hfp mutants would be expected by Taf1-2
overexpression.
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We discovered in Chapter 3 that Hfp and Tra2 together repress
M1 intron splicing, but here the same two proteins regulate Taf1
exon 12a splicing in opposite directions. Our in vivo experiments
suggested that these factors act in in parallel pathways to affect
Taf1. This conclusion is based on the observation that
overexpressed Tra2 in vivo didn't result in more exon 12a skipping.
Why might an increase in Tra2 affect exon 12a? Tra2 is known to be
expressed at relatively high levels in the male germline (Mattox
and Baker, 1991). As mentioned before, it is thought that tra2 uses
a stronger promoter to reach high protein level in a short time and
that negative feedback regulation is needed to limit these levels
from becoming deleterious. So it is likely that Tra2 levels are not
a limiting factor in promoting exon 12a skipping yet sharp
reductions in Tra2, as can result in dramatic changes. So although
Hfp is able to negatively regulate Tra2 through M1 splicing, this
limitation in Tra2 levels has no impact on Taf1 splicing. Rather
our results suggest that Hfp affects Taf1 splicing through a
separate pathway.

If exon 12a splicing is oppositely regulated by Tra2 and Hfp,
it might be predicted that in Tra2 mutants, the number of
spermytocytes in each cyst should be more than 16 or doubled to 32.
It is reported that in Drosophila ovaries (Van Buskirk and
Schupbach, 2002), Encore (enc) mutants contained 32-cell egg
chambers, while Hfp mutants had 8-cell egg chambers. These two
genes were thought to antagonize their functions in mitosis during
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oogenesis through ovarian tumor’s (otu) activity. Especially Hfp
was shown to regulate otu splicing in this process. Therefore it
was thought that Otu was responsible for the mitotic cell division
in oogenesis. However Otu is not thought to express in testis,
therefore we hypothesized the regulation of taf1 splicing in testis
would be responsible for the cell division during spermatogenesis.
However, our results from two different tra2 mutants showed only 16
spermatocyte cysts in the testes. That suggests that Tra2 probably
plays limited roles on the mitotic division, or some other factors
control mitosis are independent of Taf1 regulation.

Genes participating in a common regulatory pathway often share
similar phenotypes. We predicted that some overlap in phenotype
between Hfp and Taf1 mutants would be expected if the regulation of
Taf1-2 production is dependent on Hfp. The phenotypes observed from
both Hfp mutant and taf1 RNAi knockdowns share a number of
similarities which support the idea that these two proteins are in
a common pathway that drives meiotic events and later
spermatogenesis. Another striking similarity was observed between
taf1 RNAi mutant and other reported TAF mutants, such as no hitter
(nht) and meiosis I arrest (mia) (Ayyar, 2003; Hiller et al.,
2004). Taf1 was reported to function together with other testis
specific Tafs and also co-localize with them in testis (Metcalf and
Wassarman, 2007). Testes of Taf mutants consistently showed
significant delays in meiosis and aberrations in spermiogenesis
(Hiller et al., 2004; Hiller et al., 2001). Testes of these mutants
are generally found filled with primary spermatocytes and a small
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proportion of abnormal of later stages. The phenotypes we have
observed in taf1 RNAi knockdowns is very similar to this suggesting
that Taf1-2 could be one member of the germline TFIID complex and
have an essential role on spermatogenesis.
TFIID is a transcriptional complex containing TATA-box binding
protein (TBP) and multiple TBP-associating factors (TAFs)
(Matangkasombut et al., 2004). In Drosophila a common set of Tafs
are generally expressed (Aoyagi and Wassarman, 2001), while there
is another set of Tafs that are testis specific (Hiller et al.,
2004; Hiller et al., 2001; Metcalf and Wassarman, 2007). In general
germ line and somatic Tafs are expressed from gene paralogs.
However Taf1 is encoded by only one gene within the Drosophila
genome (Wassarman et al., 2000). The expression of a germ line
specific form of this protein (Taf1-2) is instead accomplished
through alternative splicing. In our experiments, we showed that
the testis-specific product of Taf1 is regulated by Hfp and Tra2.
Exon 12a inclusion both causes Taf1-2 enrichment in testis, and
also is critical for the normal development of the male germline.
The phenotypic similarities between Hfp and Taf1 mutants were
also supported by testing the molecular markers involved in
meiosis. Both cyclin A and twine were shown increased in Hfp and
Taf1 mutant testis. Cyclin A is a cell cycle related factor that
reaches its highest level in primary spermytocytes and disappears
abruptly before metaphase I. Its degradation is required for
spermytocytes to continue meiosis (Lin et al., 1996). In our study,
cyclin A mRNA is dramatically increased in taf1 mutant testis. This
could be due to the up-regulation of one or more factors that drive
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cyclin A expression in the taf1 mutant background. More likely it
is because more primary spermytocytes accumulated in the testis and
meiosis is significantly delayed. Twine is the Drosophila homologue
of cdc25 in mammals and is specifically involved in meiosis in both
the male and female germ line. Its mRNA first appears in early
spermytocytes and further accumulates in primary spermytocytes. It
is required for the initiation of the first meiotic division in
testes (White-Cooper et al., 1998). Its protein level is more
critical than its mRNA level for the meiosis initiation (WhiteCooper et al., 1998). In some Taf gene mutants, the testis where
meiosis is blocked, Twine levels are observed to be decreased
compared with that in wild type. In the Hfp and Taf1 mutant testis,
the level of Twine level is not decreased which is consistent with
the observation that meiosis does happen in these two mutants even
though the process is impaired as shown in figure 4-14. The dj gene
is required for the formation of spermatid and mature sperm and
also implicated in normal Nebenkern formation (Santel et al.,
1998). In vitro studies have shown that dj could be a potential
transcriptional target of Taf1 (Metcalf and Wassarman, 2006). Its
decrease in both of Hfp and Taf1 mutant testis is consistent with
our testis staining result that abnormal Nebenkern were formed and
failed elongated sperm head were seen. Also this result supports
the idea that Hfp regulates spermatogenesis partially through
regulating the splicing of taf1 exon12a.

Another interesting question is how Hfp can help Tra2 repress
M1 splicing but promote exon 12a splicing? What differences might
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exist in these substrate sequences that would be responsible for
the different behaviors of the same splicing factors?

Exon 12a has

a weak 3’ splice site in the upstream intron. It also contains two
CAAGR elements like those found in the ISS of the M1 intron as well
as a CACAGG that resembles the binding site of Tra2 in dsx
enhancer. These three elements are very close to the 3’ splice site
upstream of exon 12a and may participate in exon skipping. Studies
in mammalian cells showed that the Hfp homolog, PUF60, could
recognize weak 3’ splice sites and promote RNA splicing (Page-McCaw
et al., 1999; Valcarcel et al., 2007). Also evaluations of the
splice site strength in Taf1 pre-mRNA showed that exon 12a
contained a moderate 3’ splice site while the 3’ splice site in
exon 13 was even weaker. Hfp could function in both of the 3’
splice sites and help exon 12a inclusion. However we don’t have
information of Hfp binding specificity, it is still not clear how
Hfp can promote exon12a splicing.

Alternative splicing is a process that is extensively observed
within the transcriptome. Most genes are encoded by multiple exons
and their mRNAs are alternatively spliced (Wang et al., 2008). With
variation in developmental stage or conditions, many alternative
splicing events can be observed switched more or less in either
direction. Many splicing changes have been reported in fly mutants
and RNAi-treated cells. However, little is know that within these
splicing changes, which one has a significant consequence and which
are simply indirect noisy effect of other factors. In our study, we
discovered that a small exon of Taf1 can be regulated by two
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splicing factors and this splicing event probably is important for
normal meiosis of germ cell development in fly testis.
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Summation And Future Directions
M1 intron retention mediated by Tra2 is only seen in
Drosophila male germ line. However, this regulation occurs in
response to high transcriptional levels of Tra2 in the germline
rather than to a tissue specific factor (Mattox and Baker, 1991; Qi
et al., 2006). Therefore, although this regulation is tissue
specific in vivo, many cell types retain the competence to exert M1
repression and it has been observed that M1 retention can be
induced in either somatic tissues or cultured cells by elevating
Tra2 level (Qi et al., 2006). We took advantage of this by using
splicing reporters in a Drosophila S2 cell based RNAi screen to
identify Hfp/Puf68 as a participant in the splicing repression of
M1 intron both in cultured cells and in vivo. Both Tra2 and Hfp
were regarded as splicing activators based on studies of other
substrates (Inoue et al., 1992; Ryner and Baker, 1991; Van Buskirk
and Schupbach, 2002). However they both displayed negative
regulatory function on M1 intron splicing (Chandler et al., 2003;
Mattox and Baker, 1991; Qi et al., 2007). More interestingly, both
of these factors themselves have multiple protein isoforms but
different behaviors were observed for their effects on M1 splicing
(Mattox et al., 1996; Mattox et al., 1990). We found Hfp had two
isoforms that differ from each other in the N terminus containing
four serine-arginine dipeptides. The two isoforms were verified in
vivo, and their functional differences in S2 cells may be due to
the distinct patterns of subcellular localization. It will be
interesting to know whether similar distribution patterns are also
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present in tissues. Besides the localized distribution, a more
important question for these two isoforms is whether there are any
other functional differences between them. Does Hfp58 have the same
effect on the regulation of c-myc transcription as Hfp68 does? Does
Hfp58 also have a splicing function that is relevant in other RNA
substrates? If so, does Hfp58 display a positive regulatory role in
splicing? Like Tra2 that is predicted to have three kinds of
protein isoforms, the functions that each isoform of Hfp takes can
be tested by introducing them individually into Hfp mutant
background.

Curiously, the regulators identified so far to be involved in
repression of M1 intron splicing are all known to act as splicing
activators in other contexts. Tra2 and Rbp1 both promote female
specific splicing of both dsx pre-mRNA and fruitless pre-mRNA
(Heinrichs and Baker, 1995; Heinrichs et al., 1998; Ryner and
Baker, 1991). Hfp favors exon inclusion in the alternative splicing
of Otu pre-mRNA in Drosophila oocytes (Van Buskirk and Schupbach,
2002). Yet our findings here implicate Tra2 and Hfp as corepressors of M1 and Rbp1 was shown to be able to repress M1
splicing both in living S2 cells (Kumar and Lopez, 2005) and
nuclear extracts (Qi et al., 2007) in previous studies, even though
it showed minor activation activity in our reporter based screen. A
challenging question for the regulation of alternative splicing
therefore is how these splicing activators function together to
repress RNA splicing of M1 intron? It has been shown that Tra2
could repress M1 splicing through the CAAGR repeats of ISS element
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in vitro and Rbp1 functions independently through a small fragment
outside of the repeats in the ISS. In our studies, we found the
negative regulatory function of Hfp requires both the ISS and a
weak 3’ splice site in the intron. The phenomenon of positiondependent regulation of alternative splicing has been reported in
several splicing factors. Their regulatory roles on RNA splicing
depend on where they bind, upstream or downstream of the regulated
exons. Similarly Tra2 and other SR factors exert position dependent
effects on alternative splicing as discussed in Chapter One. Upon
binding to exons these factors help to promote exon inclusion but
repress splicing when they are bound to introns. Notably each of
the factors implicated in M1 repression, act through sequences
located within the intron. However a detailed explanation of the
mechanism of splicing repression by SR factors has yet to be
defined. Why these factors could not just promote recognition of a
weak 3’ splice site by binding to the nearby intronic elements is
unclear. Exon definition by an SR protein-containing complex offers
one potential explanation. Based on the result of our study we
speculate that Hfp represses splicing by potentially competing with
the activity of U2AF50 within the 3’ region of the M1 intron and
form another more stable complex across the whole M1 intron with
Tra2 that binds to the ISS. Eventually this big complex could
communicate with complexes formed in the flanking exons and define
the entire exon3-M1-Exon4 fragment as a single exon. This model not
only can explain the phenomenon of SR-mediated splicing repression,
but also is consistent with the observed differences in the effect
of exon verses intron bound SR factors. Usually a weak splice site
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is required for the regulation of alternative splicing and Hfp’s
vertebrate orthologue PUF60 has been specifically associated with
recognition of weak 3’ splice sites. That could be the reason why
Hfp is required for M1 retention and why a strong 3’ splice site
could abolish M1 repression in vivo. Consistent with this I
observed that when the dsx enhancer, which contains strong binding
element for Tra2 was inserted into ftz intron containing a strong
3’ splice site, it still could not mediate intron repression even
in the presence of elevated Tra2 level in S2 cells (data not
shown). To further test the above model, an intron with strong 3’
splice site could be included upstream of exon 3 and an intron with
strong 5’ splice site could be included downstream of exon 4. When
the transcript is expressed in S2 cells, Tra2 would be predicted
cause the whole exon3-M1-exon4 to be included with upstream and
downstream exons in the final mRNA.

Alternative splicing of Taf1 exon 12a was found in our study
to be regulated oppositely by Tra2 and Hfp in Drosophila testis.
Because exon 12a encodes another AT hook of Taf1 protein, its
splicing could potentially influence the transcriptional activity
of Taf1 (Metcalf and Wassarman, 2006). Further spermatogenesis in
both Hfp and Taf1 mutants were examined and similar effects between
the two mutants were recorded. These observations suggest that the
regulation of male germ cell development by Hfp is partially
through the regulation of taf1 alternative splicing. From our
rescue experiment, minor effect was seen by forced expression of
Taf1 in the Hfp mutant background. To further confirm the
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regulation of Hfp on Taf1 splicing, Taf1-2 isoform, the testisenriched isoform with exon12a inclusion, should be specifically
expressed in testis in the Hfp mutant background. This raises the
question of how Hfp plays opposite roles of Tra2 on the exon 12a
splicing. What elements within these introns or exons are required
for Hfp activation but also suffice for Tra2 repression? At present
we do not know if Hfp or Tra2 directly associates with taf1
transcript. By comparison with the situation in the M1 intron, the
mechanism of exon 12a splicing regulation by both Hfp and Tra2
could provide deeper understanding of the regulatory roles of
splicing factors in different contexts.

The splicing regulations of both M1 intron and Taf1 exon 12a
are both involved in the male germline development. Germ cell
development and differentiation is one of the most complex
processes in multi-cell organisms that alternative splicing is
known to play important roles in (Elliott, 2004; Walker et al.,
1999). By studying splicing regulation, we can understand how
tissue-specific isoforms are produced and how their alternative
splicing is employed by such tissues to produce special functions,
not only for normal germ cell growth and differentiation but also
for the abnormal incidence of certain types of cancers.

The mechanism of splicing regulation in molecular level is not
only an interesting topic but also critical to understand the
pathology of certain diseases and further provide therapeutic
choices in clinic. Recently a very promising treatment for spinal
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muscular atrophy was developed by correcting the abnormal splicing
of SMN-2 pre-mRNA with antisense oligonucleotides in mouse (Hua et
al., 2010). More successful cases will be reported to cure diseases
if the mechanisms of alternative splicing are better understood in
the future.
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